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ABSTRACT 
As the Human Immunodeficiency Virus (HIV) prevalence rises, uninfected Basotho 
face an increased risk of exposure. This necessitates strengthening of strategies that 
prevent exposure, and where exposure has occurred, measures that prevent 
infection. One such measure is Human Immunodeficiency Virus (HIV) Post-
Exposure Prophylaxis (PEP). Awareness and knowledge of HIV PEP is therefore of 
paramount importance. The purpose of this study was to assess knowledge, 
attitudes and utilisation of HIV PEP among adults in Roma, Lesotho. A quantitative 
cross-sectional study was conducted among 96 adult outpatients at St Joseph’s 
Hospital. Data were collected by means of structured questionnaire and analysed 
using SPSS version 23.0. Results were presented using charts and tables. 
Awareness of HIV PEP among the respondents was found to be very low and for 
most respondents’ knowledge of HIV PEP was either non-existent or very poor. 
Utilisation was also found to be very low. Attitudes towards HIV PEP were, however, 
found to be favourable. More studies should be conducted throughout the country to 
further explore Basotho’s knowledge, attitude and use of HIV PEP. 
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CHAPTER 1: ORIENTATION TO THE STUDY 
 
1.1 INTRODUCTION 
 
The purpose of the study was to assess knowledge, attitudes and utilisation of HIV Post-
Exposure Prophylaxis among adults in Roma, Lesotho in order to make 
recommendations for promoting awareness and the use of HIV PEP among adults in 
Roma, Lesotho. The HIV pandemic has a devastating impact in Lesotho (Ministry of 
Health [MoH] 2014: viii). It is affecting the population, the economy and the country’s 
health care system (MoH 2013:v). More than 23% of Basotho are living with HIV, this 
approximates to 380000 people, of which 342000 are adults (MoH 2014: viii). According 
to the MoH (2014:viii), HIV prevalence is highest (44.0%) in the age group 35-39, followed 
by 40.8%, 22.4% and 10.9% in the age groups 30-34, 20-24 and 15 -19 respectively.  
 
In 2012, Lesotho had the third highest HIV prevalence in the world (Lesotho Times 
2012:1) and in just two years, the prevalence has risen, and the country now ranks 
second highest in the world. More people in Lesotho have died of HIV/AIDS related 
conditions than any other disease (Elizabeth Glaser Pediatric AIDS Foundation 
(EGPAF 2014:1).  
 
This chapter provides a background to the study, problem statement, purpose and 
objectives of the study, significance of the study, research questions, definitions of key 
concepts used in the study. The chapter also provides the synopsis of research design 
and methods used in the study and the layout of the entire dissertation 
 
1.2 BACKGROUND TO THE RESEARCH PROBLEM 
 
Human Immunodeficiency Virus (HIV) is still a global health issue. It is estimated that 
36.9 million people were living with HIV globally at the end of 2014 (The Joint United 
Nations Programme in HIV/AIDS [UNAIDS] 2015:1). Since 1983, HIV prevalence has 
rapidly risen, especially in Sub-Saharan Africa. UNAIDS (2015:1) indicated that in 
2014, there were 25.8 million people living with HIV and 790 000 died from HIV 
related conditions in the Sub-Saharan Africa. The same report highlighted the fact 
that this region had 1.4 million new HIV infections, accounting for 70% of the total 
new HIV infections in Africa. According to the World Health Organization (WHO) 
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(2016:1), Sub-Saharan Africa accounts for two-thirds of the global total of new HIV 
infections.  
 
Lesotho, which is one of the Sub-Saharan Africa countries, is among the countries 
with highest HIV prevalence in the World (MoH 2013:1). It has been over three 
decades now since the country started to fight HIV, and still cure for this pandemic 
has not yet been found; however, there is hope as drugs have been developed to 
limit the spread of the virus and to allow infected individuals to live longer and 
healthier lives (WHO 2014:1). These antiretroviral drugs (ARVs) are also used by HIV 
uninfected individuals as Pre-Exposure Prophylaxis (PrEP) and Post-Exposure 
Prophylaxis (PEP) to prevent acquisition of HIV infection. In the HIV context, PrEP 
refers to ARV medication initiated “before” high-risk exposure whereas PEP as a 
preventive measure, is initiated shortly following a high-risk exposure to HIV (United 
States Agency for International Development [USAID] 2013:74-75).   
 
In 2011, a trial which involved 4758 heterosexual serodiscordant couples in Kenya and 
Uganda showed that the HIV negative partners who took PrEP were 62% less likely to 
be infected with HIV than those who were receiving placebos (Baeten, Donnell, Ndase, 
Mugo, Campbell, Wangisi,Tappero… & Celum 2012:16). Since HIV PEP uses the 
same principle as HIV PrEP, which is to give a person’s immune system a chance to 
provide protection against the virus and to prevent HIV from being established in the 
body (USAID 2013:75), it is assumed that HIV PEP would work effectively as HIV 
PrEP.. 
 
Since early 1990s, HIV PEP has been prescribed following occupational exposure to 
HIV. The provision of HIV PEP has been extended to non-occupational exposures 
such as: consensual unprotected sexual intercourse, injection drug use and sexual 
assault (WHO 2014:15). According to the New York state Department of Health AIDS 
Institute (2014:2), HIV transmission most frequently occurs during sexual or injection-
drug use. Center for Disease Control (CDC) (2014:1) states that HIV PEP can reduce 
the risk of infection if it is started promptly after exposure to HIV risk sexual behaviour. 
Examples of HIV risk sexual behaviours are unprotected sexual contact between an 
infected and an uninfected individual and condom non-use/slippage/breakage. Mayer 
and Pizer (2009:129) stated that providing PEP to people with a well-defined high-risk 
sexual exposure could reduce the likelihood of HIV transmission by 10-fold”.   
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The HIV PEP is now used worldwide after either occupational or non-occupational 
exposure (Rey 2014:1). Even with the extensive global dissemination of information on 
HIV/AIDS prevention aspect such as HIV PEP is mostly not taken seriously. Limited 
HIV PEP information is also prevalent among health care providers. Owalabi, Alabi, 
Ajay, Daniel, Ogundiran, Akande and Onafowokan (2012:2), document that knowledge 
about PEP among health care providers is limited. Furthermore Mukherjee, 
Bhattacharyya, SharmaSarkar, Goswami, Ghosh and Samanta (2013:14) conducted a 
study among interns of a medical college in India where they also reportedthat 
knowledge of PEP was inadequate. In another study by Methewos, Birhan, Kinfe, Boru, 
Tiruner, Addis and Alemu (2013:2) it was highlighed that 36.9% (72 out of 195) of the 
health care workers had inadequate knowledge regarding HIV PEP. This is a significant 
number considering that this is a group of people who are expected to be highly 
knowledgeable about issues of HIV. 
  
World Health Organization (WHO) and the Government of Lesotho (GoL) through the 
Ministry of Health have approved the use of HIV PEP as a preventive measure against 
HIV (MoH 2014: v). The country has been providing ARV treatment for more than a 
decade now, this kind of experience means that the country has acquired the capability 
and infrastructure to avail services even to the remotest areas within its borders. ARV 
treatment in Public health facilities in Lesotho is provided free of charge.  
 
1.3 STATEMENT OF THE RESEARCH PROBLEM 
 
Approximately 62 new infections and about 50 deaths due to AIDS are reported to occur 
daily in Lesotho (Ministry of Health (MoH) 2014: viii). This is occurring despite the 
approval of providing HIV PEP to the community following non-occupational exposure as 
HIV preventive strategy by the Lesotho Ministry of Health (MoH 2014: viii). Studies have 
shown that health care providers have limited knowledge about HIV PEP (Owalabi et al 
2012:2; Mukherjee et al 2013:14; Methewos et al 2013:2). However, there is dearth of 
literature focusing on adults’ knowledge, attitudes and utilisation of HIV PEP. If this 
information is not available, HIV infection may still continue to rise daily in Lesotho despite 
the free availability of HIV PEP. The continuing rise in HIV prevalence negates global 
vision to end the HIV pandemic (UNAIDS 2015: xx). 
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1.4 RESEARCH PURPOSE AND OBJECTIVES 
 
1.4.1 Research purpose 
 
The purpose of the study was to assess knowledge, attitudes and utilisation of HIV Post-
Exposure Prophylaxis among adults in Roma, Lesotho in order to make 
recommendations for promoting awareness and the use of HIV PEP among adults in 
Roma, Lesotho 
 
1.4.2 Research objectives 
 
 To assess the knowledge of adults in Roma regarding HIV PEP following non-
occupational exposure, 
 To explore the attitudes of adults in Roma regarding the use of HIV PEP, 
 To assess utilisation of HIV PEP services by adults in Roma. 
 To determine accessibility to PEP services to adults in Roma, 
 To recommend strategies for promoting awareness and the use of PEP among 
adults in Roma, Lesotho 
 
1.5 RESEARCH QUESTIONS 
 What knowledge do adults in Roma have regarding non-occupational HIV PEP?  
 What are the attitudes of adults in Roma towards HIV PEP?  
 How accessible are HIV PEP services for adults in Roma? 
 What is the rate of HIV PEP utilisation by adults in Roma? 
 How can awareness and utilisation of HIV PEP by adults in Roma be promoted? 
 
1.6 SIGNIFICANCE OF THE STUDY 
The study was vital at this point because Lesotho is facing a major crisis with the 
HIV/AIDS pandemic. New infections occur daily and many lives are lost due to this 
pandemic. The researcher is of the opinion that the findings of this study may be utilised 
to influence guidelines and policy on promotion of utilisation of HIV PEP. Services, 
therefore, need to be fully utilised by the general public to try and curb the increasing 
numbers of new infections. The hospital and other health care facilities serving this 
community will also become aware of the need to mobilise HIV PEP services. The 
Ministry of Health, as well as other stakeholders concerned in the fight against HIV/AIDS 
and the entire nation of Basotho, will also reap the benefits. The findings will also add to 
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the existing knowledge with regard to HIV PEP. Improved utilisation of HIV PEP may 
assist in reduction of new HIV infections in Roma, Lesotho and eventually contribute to 
global vision to end the HIV pandemic by 2030. 
 
1.7 DEFINITION OF TERMS 
 
1.7.1 Definitions of key concepts 
 
A conceptual definition conveys the general theoretical meaning of the concept being 
defined, and uses words/concepts to describe its properties (Brink, van der Walt, C & van 
Rensburg G 2014:91). Below are definitions of key concepts. 
Adult: One who is considered to be legally responsible for their actions, (Longman 
dictionary of contemporary English 2003:21)  
Attitude: the opinions and feelings that one usually has about something; it can be 
positive or negative, (Longman dictionary of contemporary English 2003:82). 
Human Immunodeficiency Virus (HIV): is a virus that causes AIDS, (van Dyk 2013:5). 
Human Immunodeficiency Virus Post-Exposure Prophylaxis (HIV PEP): an HIV 
prevention approach for uninfected individuals to decrease chances of being infected by 
ingesting Antiretroviral (ARV) medication following exposure to potentially infected body 
fluids (USAID 2013:75).  
Knowledge: the information, skills and understanding that one gains through learning or 
experience (Longman dictionary of contemporary English 2003:895). 
Post-Exposure Prophylaxis: the administration of antibiotics, antiviral agents, or active 
and or passive vaccination following an exposure to an infectious agent (Weller 
2014:328). 
Utilise: to use something for a particular purpose (Longman dictionary of contemporary 
English 2003:1825). 
 
 
 
 
 
1.7.2 Operational definitions 
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According to Brink et al (2014:91), variables and terms in the research question have to 
be operationalized; that is, defined so that their meaning is clear to both the researcher 
and the reader. An operational definition describes the manner in which a variable is to 
be measured (Brink et al 2014:91). This section provides operational definitions.  
Adult: A man or woman aged 18 years and above. 
Attitude: opinions and feelings that one has about HIV PEP. It can be positive/favourable 
(when one accepts and supports the use of PEP) or negative/unfavourable (when one 
rejects the idea of using PEP).   
Knowledge: the information and understanding that one has about HIV PEP. This can 
be non-existent/very poor (where one knows nothing about HIV PEP), deficient/poor (one 
knows a little about PEP) or adequate (one knows what HIV PEP is and understands 
indications for its use). 
Non-occupational exposure: HIV exposure that is not related to or caused by one’s job. 
This can be HIV exposure through sexual exposure, injection drug use, administering first 
aid to injured individuals or other exposures.  
Post-Exposure Prophylaxis: a set of services, which includes provision of antiretroviral 
drugs; provided to manage the specific aspect of exposure to HIV and to help prevent 
HIV infection. 
Utilisation of HIV PEP: accessing HIV PEP services from health care facilities. This can 
be poor (when only a few people use these services) or good (when a considerable 
number of people use these services). 
 
1.8 RESEARCH METHODOLOGY 
 
1.8.1 Research approach 
 
The study employed a quantitative approach to assess knowledge, attitudes and 
utilisation of HIV Post-Exposure Prophylaxis among adults in Roma. Polit and Beck 
(2012:739) define a quantitative research approach as one that investigates observable 
occurrences that are subject to precise measurement and quantification.  
 
1.8.2 Research design  
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Brink, van der Walt & van Rensburg (2014:96) define research design as a set of logical 
steps that the researcher takes in order to answer the research question. The researcher 
used a descriptive cross-sectional design. More information regarding the design is 
provided in chapter three.  
In a cross-sectional design, data are collected at one point in time (Polit & Beck 
(2012:184), and such was the case in this study. De Vos, Strydom, Fouche and Delport 
(2013:155,156) describes non-experimental designs as designs that are mainly used in 
descriptive studies in which the units selected to participate in the study are measured on 
all relevant variables at a specific time, and there is no manipulation of variables. In 
support of this Brink, van der Walt & van Rensburg (2014:112) state that a 
nonexperimental research aims to describe an occurrence and to explore and explain 
how variables are related, without any intervention whatsoever. Furthermore, Brink et al 
(2014:112) continue to define a descriptive study design as one that describes variables 
so as to answer the research question. This study was nonexperimental and descriptive 
in that the researcher did not in any way manipulate variables but just provided a 
description of how much people know about HIV PEP, how many have accessed HIV 
PEP and what their attitudes are regarding HIV PEP.  
1.8.3 Setting and population 
 
A research setting is defined as the specific place where data are collected, (Brink et al 
2014:59). The fieldwork of the study was carried out at St Joseph’s hospital in Roma, in 
the district of Maseru. Polit and Beck (2012:738) define population as “the entire set of 
individuals or objects having some common characteristics”. The population of this study 
comprised of both male and female adults of Roma. 
 
1.8.4 Sampling method and technique 
 
Polit and Beck (2012:275) define sampling as a process of selecting a portion of the 
population that is representative of the entire population. The selected portion is then 
referred to as a “sample”. The sample of this study was 96. The sample size was 
calculated using the sample size calculator from Survey Monkey Inc and the study 
employed stratified random sampling to select the respondents. A more detailed 
discussion follows in Chapter 3, section 3.4.2. 
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1.9 DATA COLLECTION 
Data were collected from April to June 2016, using structured questionnaire. Data 
collection process will be discussed in detail in Chapter three, section 3.4.4. 
 
1.10 DATA MANAGEMENT AND ANALYSIS 
Polit and Beck (2012:725) define data analysis as the systematic organization and 
synthesis of data. Following collection, all raw data were reviewed for completeness and 
accuracy and then kept under lock and key for safety. Data were then reviewed for 
legibility, and data gaps were addressed (Polit & Beck 2012:463). The collected data were 
then analysed using Statistical Package for Social Sciences (SPSS) version 23.0. Results 
were presented in tables, charts, and interpreted. A more detailed discussion on data 
analysis will be made in Chapter 3, section 3.4.5 and results are presented in Chapter 4. 
 
1.11 ETHICAL CONSIDERATIONS  
According to Brink et al (2014:32), researchers are responsible for conducting research 
in an ethical manner. This section provides a brief discussion on ethical issues. A more 
detailed discussion will follow in Chapter 3, section 3.4.3. Following submission of the 
research proposal, the Higher Degrees Committee of the Department of Health Studies 
at the University of South Africa gave approval to the researcher to conduct the study. 
Permission was also sought and granted by the Ministry of Health Research Ethics 
Committee and the Management of St Joseph’s hospital. Respondents were informed 
about the purpose of the study and participation was voluntary. 
 
1.12 SCOPE OF THE STUDY 
The study was limited to assessing the knowledge, attitudes and utilisation of HIV PEP 
among adults utilising out-patient department at St Joseph’s Hospital in Roma within April 
and June 2016.  
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1.13 STRUCTURE OF THE DISSERTATION 
This section outlines the structure of the dissertation:  
Chapter one, Orientation to the study, provides a background to the study, the research 
problem including research purpose and objectives, ethical issues as well as the 
methodology used.  
Chapter two focuses on reviewed relevant HIV PEP literature in general and knowledge, 
attitudes and utilisation/practice of HIV PEP.  
Chapter three provides a detailed discussion on the research design and methodology. 
More information is provided on study site, sampling method, data collection and analysis, 
measures to ensure trustworthiness and ethical issues related to the study. 
Chapter four presents the study results in the form of graphs and tables.,  
Chapter five provides discussion of findings, conclusions, limitations as well as 
recommendations.  
 
1.14 CONCLUSION 
This chapter gave an overview of the whole study. The chapter outlined background and 
context of the study. The problem statement, purpose of the study, objectives as well as 
research questions were highlighted. The next Chapter discusses the literature review. 
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CHAPTER 2: LITERATURE REVIEW 
 
2.1 INTRODUCTION 
In the previous Chapter, the research problem that inspired the study was stated, as thus: 
Lesotho’s increasing HIV prevalence despite the extensive dissemination of services and 
information on prevention measures. An assumption was made that one of the 
contributing factors to the rise in prevalence could be lack of knowledge regarding HIV 
PEP as another preventive strategy. This Chapter therefore serves to critically review 
existing literature on the knowledge, attitudes and use of HIV PEP among adults, the 
purpose of which is to guide and direct the study in order to prove or confute the 
aforementioned assumption.  
 
Polit and Beck, (2012:732) define literature review as a critical summary of research on 
a topic of interest, the purpose of which is to put a research problem in context. Polit and 
Beck (2012:94) further state that research is conducted within the context of existing 
knowledge by undertaking a thorough literature review. According to Grove, Burns and 
Gray (2015:41) the purpose of literature review is to generate a picture of what is known 
and not known about a particular problem. It also provides the rationale for conducting a 
specific study.  
 
Studies on HIV PEP following non-occupational exposure are quite scarce. However, 
information on HIV PEP following occupational exposure in Health Care settings is 
available and will mainly be used in this study. About 2.5% of the total global number of 
people living with HIV results from occupational exposures among health care workers 
(Singh, Din Ahmad, Munner, Sabah, Baig & Khan (2015:1). These authors agree that 
health care worker’s jobs bring them in direct and close contact with patients’ body fluids, 
putting them at a higher risk of occupational exposure to HIV. 
 
The Chapter discusses the search strategy that was used when searching for literature, 
appraisal of reviewed studies, themes that emerged, a brief discussion on HIV PEP and 
literature on International and African perspectives on knowledge, attitude and 
use/practice of HIV PEP. 
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2.2 SEARCH STRATEGY 
Polit and Beck (2012:98) show that there are several ways to search for research 
evidence, and advise to begin a search with some strategies in mind. The researcher 
utilised a systematic approach to conduct a thorough literature search. The University of 
South Africa (UNISA) library was used for literature search related to knowledge, attitudes 
and utilisation of HIV PEP among adults. The search included published studies and grey 
literature, the former being considered worthy as evidence because of the peer review 
system and the latter was included because of the “publication bias” defined by Polit and 
Beck (2012:657) as “the tendency for published studies to over-represent statistically 
significant findings”. The researcher mainly used Google scholar articles and electronic 
databases such as HINARI, Cochrane, ProQuest, Medscape and CINAHL for a broader 
perspective on the topic. 
 
The following key words and phrases were used to search for the literature: “knowledge”, 
“attitudes”, “use”, “practice”, “HIV PEP” and “HIV non-occupational PEP”. The above 
search terms were initially used individually, and then combined using Boolean logic 
(AND, OR and NOT) to formulate a search strategy rather than the dissertation title. In 
order to guide the process of literature review on the topic, the following inclusion and 
exclusion criteria were utilised: 
Inclusion: 
 Studies published after 2010 
 Studies published in English 
 Studies that assessed/evaluated knowledge, attitudes and use/practice of HIV 
non-occupational PEP among adults 
 Studies that assessed/evaluated knowledge, attitudes and use/practice of HIV 
occupational PEP 
 
Exclusion: 
 Studies published in or before 2010 
 Studies published in languages other than English 
 Studies that did not assess/evaluate knowledge, attitudes and use/practice of HIV 
PEP 
 Studies conducted among underage children 
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The ancestry approach, which involves use of citations from relevant studies in order to 
track down earlier research on the topic, was also utilised. Leads were then pursued until 
search strategies yielded redundant information. 
  
2.3 APPRAISAL OF IDENTIFIED STUDIES  
When drawing conclusions about a body of research, the researcher must make 
judgements about the worth of the evidence (Polit & Beck 2012:111). This section 
discusses issues pertaining to appraisal of identified studies. After application of the 
above inclusion and exclusion criteria, lead sources were pursued until saturation was 
achieved. The sources were then screened for appropriateness and relevance and 
inappropriate and irrelevant sources were discarded. The information was then 
evaluated, analysed and interpreted. All sources that met the inclusion criteria were 
critically examined for inclusion in the review. The selected studies were then reviewed 
using the guidelines for critiquing data quality in quantitative studies offered by Polit and 
Beck (2012:34). The studies were evaluated according to their reliability and validity (Polit 
& Beck 2012:347). 
2.4 EMERGENT THEMES 
 
Two themes and several subthemes emerged from appraisal of reviewed literature as 
summarised in Table 2.1.  
Table 2.1: Emerged themes 
 
Themes Sub-themes 
Overview of HIV PEP 
 
What is HIV PEP 
History of HIV PEP 
Indications for HIV PEP 
Rationale for HIV PEP 
Evidence of PEP 
efficacy 
Knowledge, attitude and utilisation /practice 
of HIV PEP: 
International perspective 
African perspective 
Implication of the findings  
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2.4.1 Overview of HIV PEP 
This theme provides description, history, indication and rationale and efficacy of HIV PEP. 
2.4.1.1 What is HIV PEP? 
The United Nations programme on HIV/AIDS (UNAIDS) (2013:75) defines HIV PEP as 
an HIV prevention approach for uninfected individuals to decrease chances of being 
infected by ingesting Antiretroviral (ARV) medication following exposure to potentially 
infected body fluids. The medication is started immediately after exposure, that is, within 
72 hours of exposure in order to prevent HIV seroconversion.  
 
According to Shevkani, Kavina, Kumar, Purohit, Nihalani and Shah (2011:2,3) PEP 
services are a set of comprehensive services that are aimed at preventing HIV infection 
in persons, exposed either occupationally or non-occupationally, and a provision of short 
term (28 days) ARV drugs depending on the risk assessment. These services also include 
counselling, first aid care, HIV testing and follow-up care (WHO, 2016:1).  
  
2.4.1.2 History of HIV PEP 
The use of antiretrovirals as HIV PEP for occupational exposures was first considered in 
guidelines issued by the Center for Disease Control and Prevention (CDC) in 1990 
(Kuhar, Hendreson, Struble, Heneine, Thomas, Cheever, Gomaa, Panlilio & US Public 
Health working Group 2013:875). In most areas of North America and Europe HIV PEP 
has been available to health care workers as a component of workplace safety programs 
since early 1990s (UNAIDS 2013:75). In 1996, the first US (United States) Public Health 
Service recommendations advocating the use of HIV PEP following occupational 
exposure were published (Kuhar et al, 2013:875). According to Beekmann and 
Henderson (2014:2), A case control study of HIV seroconversion in health care workers 
(HCW) after percutaneous exposure published in 1997 provided the first evidence in 
humans that PEP with a single antiretroviral agent appeared to be protective against 
infection. 
 
It was; however, only in 2005 that the US Department of Health and Human Services 
issued clinical guidelines recommending use of PEP in non-occupational situations 
(Kuhar et al 2013:875). In response to high violence levels, sexual assault and the 
associated high risk of HIV exposure, some hospitals and Non-Governmental 
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Organizations (NGOs) in South Africa pioneered the use of PEP following sexual 
exposure (USAID 2013:75).Today anybody who has been exposed to HIV can request 
PEP services. 
 
2.4.1.3 Indications for HIV PEP 
Protection against HIV exposure (e.g. abstinence from sexual intercourse, abstinence 
from shared injection drug use, sexual intercourse only in a mutually monogamous 
relationship where both partners are uninfected, consistent and correct condom use) is 
the only certain way of preventing HIV infection. However, when the primary measures 
have failed and exposure has occurred, secondary measures have to be in place to 
reduce the probability of being infected. The HIV PEP is one such measure and it has 
been proven efficient if initiated timely and strictly adhered to (Kuhar et al 2013:875). 
 
According to HIV Clinical Resource (2014:4), non-occupational PEP (nPEP) offers the 
possibility of preventing HIV transmission when potential exposure to HIV has already 
occurred. Situations that may prompt one to request nPEP include condom slippage, 
breakage, or lapse in use by serodiscordant partners; unsafe needle-sharing; or other 
episodic exposures to blood (USAID 2013:75). Treatment of high-risk exposures should 
be combined with a strong educational component that emphasizes prevention of future 
exposures (HIV Clinical Resource 2014:4). PEP should therefore only be used in 
emergency situations (AIDS gov 2016:1). 
 
The WHO and USAID recommend the use of PEP in the following settings: 
 Occupational exposure 
 Non-occupational exposure 
 
2.4.1.4 Rationale for HIV PEP 
Volberding, Greene, Lange, Gallant and Sewankambo (2012:118) state that after an 
individual has been exposed to HIV, there is a small window of opportunity to use 
antiretroviral drugs to prevent systemic infection. This strategy has been shown to prevent 
HIV infection in both occupational and non-occupational exposures. The effectiveness of 
HIV PEP in preventing establishment of HIV infection; however, is dependent on a 
number of factors, namely: route and dose of exposure, efficacy of drug(s) used, interval 
 15 
 
between exposure and initiation of drug(s) and level of adherence to the treatment 
(Volberding et al 2012:118-119). Currently, the consensus is that combination of 
antiretroviral therapy (ART) should be initiated as soon as possible following exposure, 
and continued for four weeks (28 days) (HIV Clinical Resource 2014:4).  In order to 
minimise the possibility of behavioural disinhibition among individuals receiving HIV PEP 
for sexual or drug use exposures, the provision of PEP be accompanied by behavioural 
counselling following such exposures (Volberding et al 2012:119). 
 
The aim of HIV PEP is to give a person’s immune system a chance to provide protection 
against the virus and to prevent HIV from being established in the body (USAID 2013:75). 
Experimental models of HIV infection engage in the following sequence of events: After 
percutaneous or mucosal exposure to HIV, local replication of virus occurs in tissue 
macrophages or dendritic cells; host cytotoxic T cells will kill productively infected target 
cells. However, if infection cannot be contained at this stage, it is followed within 2 to 3 
days by replication of HIV in regional lymph nodes; viremia then follows within 3 to 5 days 
of virus inoculation (HIV Clinical Resource 2014:4).This sequence of events carries 
significant implications. Given the rapid appearance of productively infected cells 
following the introduction of virus, regimens with the most rapid onset of activity, multiple 
sites of antiviral action, and greatest strength are likely most effective (HIV Clinical 
Resource 2014:4). Aminde, Takah, Noubiap, Tingdon, Ngwasiri, Jingi, Kengne and 
Dzudie (2015:3) state that it may take 3 days (72 hours) from exposure for HIV to be 
detected in lymph nodes and up to 5 days in blood, offering a very short window of 
opportunity for prevention through HIV PEP. The HIV PEP works by suppressing viral 
replication and stopping the irreversible establishment of HIV infection (Aminde et al 
2015:3).  
 
2.4.1.5 Evidence of HIV PEP efficacy 
According to the HIV Clinical Resource (2014:4), there are no studies that directly 
demonstrate the efficacy of nPEP, but there are data to support its biologic plausibility, 
including animal studies of prophylaxis following exposure,   efficacy data from mother-
to-child transmission studies and a case-control study of occupational exposure. To 
corroborate these, Aminde et al (2015:3) state that efficacy in humans is supported by 
retrospective data from occupational exposure studies and studies on prevention of 
mother-to-child transmission (PMTCT).  
 16 
 
 
2.4.2 Knowledge, Attitude and Utilisation/Practice of HIV PEP 
 
2.4.2.1 International perspective 
In a study that dealt with nPEP in New York, Mehta, Silvera, Bernstein, Holzman, Aberg 
and Daskalakis (2011:1) assessed awareness of HIV Post-Exposure Prophylaxis and the 
associated factors amongst 554 men who have sex with men. Sixty three percent (63%) 
of the respondents reported unprotected sex and 7% reported any 
(protected/unprotected) sex with a known HIV infected partner (Mehta et al 2011:1). This 
clearly shows that some populations still demonstrate risky sexual behaviours even in the 
presence of known HIV infection. This calls for more aggressive measures in educating 
people about HIV. Only 36% of the respondents were aware of PEP or PrEP (Mehta et 
al 2011:1).  
 
Study conducted Fernandez-Balbuena, Belza, Castilla, Hoyos, Rosales-Statkus, 
Sanchez, de la Fuente and the Madrid Rapid Testing group (2012:2) indicated that only 
22% of the 2545 respondents were aware of PEP, and only 2% had used PEP before 
despite 70% participation in high-risk sexual activities. The two studies concluded that 
awareness of PEP was very low despite exposure to HIV high risk sexual behaviours. 
 
Myers, Myers, Wheat and Yin indicated that knowledge about post-exposure 
management was poor (25%) among dental students. Results also indicated that 8.2% 
of the respondents also acknowledged unwillingness to do procedures on HIV infected 
patients for fear of being exposed (Myers et al 2011:1-2). This warranted the need for 
knowledge assessment as the unwillingness to assist HIV infected clients might have 
been influenced by deficient knowledge on prevention and management of exposures. In 
the study, Myers et al (2011:1) concluded that there were knowledge gaps among the 
respondents and these may lead to failure to manage blood borne pathogen exposures 
accordingly, and also the negative attitudes towards treating HIV infected patients affects 
care of such patients. Therefore, there is need to improve education on blood borne 
pathogen exposures in dental schools. 
 
A similar study was conducted in 2011 by Guruprasad and Chauhan in India, where they 
evaluated knowledge, attitudes and practices regarding risk of HIV infection through 
accidental needle stick injuries amongst 120 dental students. Results revealed that 13 of 
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the 120 respondents were not even aware that virus can be transmitted through an 
infected needle (Guruprasad et al 2011:155). This is an indication that more still needs to 
be done to educate people about HIV transmission. On management of the needle stick 
injury 26% said they would promote active bleeding at the affected site to flush out the 
pathogens, and 30% said they would take PEP. It was then concluded that there were 
misconceptions that needed to be addressed and also there was need to provide 
guidelines on management of needle stick injuries.  
 
In another study titled “Knowledge and Practice of Standard Precautions and awareness 
Regarding Post-Exposure Prophylaxis for HIV among interns of a Medical College in 
West Bengal, India” Mukherjee, Bhattacharyya, SharmaSarka, Goswami and Ghosh 
(2013:2) revealed a considerable gap between knowledge and practice among the 130 
respondents. The above three studies are a clear indication that education on HIV and its 
prevention should start in Health Schools to ensure more knowledgeable future 
professionals. 
 
Lamichanne, Aryal and Dhakal (2012:1) conducted a descriptive cross-sectional study 
involving 65 nurse respondents in Nepal, where to assess knowledge on different 
variables on PEP and HIV. Of the 65 respondents, only 6% had what was classified as 
good level of knowledge, 68% had fair knowledge and 26% had poor knowledge. It was 
then concluded that HIV PEP knowledge among the respondents was fair and there was 
need for improvement through education and training.    
 
Rodriguez, Castel, Parish, Willis, Feaster, Kharfen, Gardenas, Villamiza, Kolber, 
Vazquez-Rivera and Metsch (2013) investigated HIV medical providers’ perceptions of 
the use of Antiretroviral therapy as non-occupational Post-Exposure Prophylaxis in two 
major Metropolitan areas, namely Columbia and Miami. Findings indicated underuse of 
nPEP as a preventive measure against HIV, one of the reasons being that patients rarely 
requested nPEP (Rodriguez et al 2013:2, 19). As indicated by earlier studies, people may 
not be aware of PEP and thereby justifying the rarity of PEP requests. 
 
In their study Purov, Palummieri, De Carli, Piselli and Ippolito (2013), assessed attitude 
towards antiretroviral Pre-Exposure Prophylaxis (PrEP) prescription among 311 HIV 
specialists. Findings revealed favourable attitudes with 70% of the specialists indicating 
that they would prescribe PEP, mainly to serodiscordant couples (64%), 56% would also 
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prescribe to people at on-going high risk of infection. Those with a negative attitude 
towards the prescription of PEP favoured behavioural interventions and were also 
concerned about the toxicity of the drugs. The negative attitude was also associated with 
lack of information on PEP. Most specialists seem to be willing to promote PEP even with 
the evident conflicting attitudes. Guidance from the responsible bodies and more scientific 
evidence on effectiveness may help develop favourable attitudes towards PEP (Purov et 
al 2013:2). 
 
Shaghaghian, Pardis and Mansoori (2014) evaluated knowledge, attitude and practice of 
dentists towards prophylaxis after exposure to blood and body fluids, in Shiraz. All three, 
knowledge, attitude and practice, were found to be undesirable among the respondents, 
warranting interventions to raise awareness (Shaghaghian et al 2014:147-152). 
 
In another related study, Singh, Din Ahmad, Baig and Khan (2015) assessed 609 HIV 
health care workers in Lahore Pakistan on the knowledge, attitude and practice of HIV 
PEP. Findings in the study revealed that almost half of the respondents had never heard 
of PEP, 68% were of the opinion that PEP guidelines should not be listed in the working 
area, and 47.2% believed that PEP was not protective against HIV (Singh et al 2015:2). 
Provision of information and evidence of PEP use are needed to rectify the lack of 
awareness and negative attitudes. Internationally, HIV prevalence is not as high as it is 
in Africa, in fact, it is very low. That is the reason why there seems to be an overall lack 
of awareness and knowledge amongst both the general public and Health care workers. 
 
2.4.2.2 African perspective 
HIV prevention is of public importance in Sub-Saharan Africa as it is endemic in this 
region, this increases the risk of health care providers contracting the virus through 
occupational exposure (Uzochukwu, Sibeudu, Ughasoro, Okwuosa & Onwujekwe 
2014:4). Uzochukwu et al (2014:4) further state that health care workers are at risk of 
exposure through contaminated medical materials and infective body products.  
 
Another study was undertaken by Chagani, Manji, Manji and Sheriff in 2011. They 
conducted a hospital based study involving 316 health care workers in Dar es Salaam, 
where they investigated knowledge, attitude and practices on HIV PEP. Results showed 
that 169 out of the 316 workers had been exposed. Only 41 of the exposed had taken 
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PEP and 40% of the 41 failed to complete the 28 day treatment. Only a third of the study 
population knew the initial steps to be followed after exposure. However, knowledge on 
HIV PEP was found to be satisfactory among most respondents. The study concluded 
that there is a need to heighten education on PEP among health care workers (HCWs) in 
order to increase their awareness and knowledge (Chagani et al 2011:1). 
 
In a study conducted among 66 doctors in a Nigerian Tertiary hospital in 2011, Esin, Alabi, 
Ojoe and Ajape documented that knowledge of HIV PEP was very low. Only 62.1% of the 
respondents were aware of the existence of an HIV PEP policy in the hospital, over 90% 
were not aware of the risk of sero-conversion following significant needle stick injuries 
and mucous membrane exposures. Poor knowledge was also identified with regard to 
actions to be taken following exposure, how soon to commence PEP and the duration of 
the PEP medication. More than 50% of the subjects reported to have experienced 
significant previous exposures to potentially infective materials but none of them reported 
to have sought PEP advice (Esin et al 2011:2). The two studies also show that exposures 
are high among HCWs and therefore their prevention needs to be addressed. 
 
In a study titled “Percutaneous injuries and accidental blood exposure in Surgical 
residents: Awareness and use of Prophylaxis in relation to HIV”, Nwankwo and Aniebue 
(2011) revealed a deficiency in knowledge and poor practice of PEP among the surgical 
residents underscoring the need for creating awareness. 
 
Owolabi, Alabi, Ajayi, Daniel, Ogundiran, Akande and Onafowokan (2012) conducted a 
cross-sectional survey amongst 230 health care providers at the University of Abuja 
Teaching Hospital in Nigeria. Results indicated that most of the respondents (97%) had 
heard about PEP, but only 30% of them could correctly identify the drugs used and the 
duration of PEP. A conclusion was then made that the health care providers’ knowledge 
and practice was very poor (Owolabi et al 2012:2). 
 
Another study that revealed misconceptions regarding management of exposures in 
health care settings was conducted by Sabbah, Sabbah, Sabbah, Akoum and Droubi 
(2013) in Lebanon. This was a cross-sectional study amongst 272 health care workers in 
general hospitals, where knowledge, attitude and practices concerning blood borne 
pathogens and adherence to universal safety precautions were evaluated. Results 
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showed that respondents incurring exposures to blood and body fluids resorted to other 
means (Sabbah et al 2013:70-78).  
 
Mathewos, Birhan, Kinfe, Boru, Tiruneh, Addis and Alemu (2013) carried out a cross-
sectional study amongst 195 Health care workers in Gondar, Ethiopia, where they 
assessed knowledge, attitude and practice of HIV PEP. 36.9% of respondents in this 
study were found to have deficient knowledge regarding HIV PEP. In the study, Mathewos 
et al (2013:9) highlighted that 75.4% of their subjects agreed on the importance of HIV 
PEP and 78.5% strongly believed that PEP can reduce the probability of being infected 
by HIV following exposure. 
 
Ajibola, Akinbami, Elikwu, Odesanya and Uche (2014) conducted a cross sectional study 
with self-administered questionnaires among 372 health workers from various clinical 
specialties in a Teaching hospital in Lagos, Nigeria. Results of the study revealed that 
83.3% of the respondents were aware of PEP, but level of knowledge was low as only 
32% could name at least two of the recommended drugs for PEP and 54% knew when to 
commence PEP following HIV exposure. Uptake of PEP was reported to be very low 
(6.3%) despite frequent needle stick injuries and favourable attitudes toward PEP (Ajibola 
et al 2014:17,172). 
 
A related cross-sectional study was conducted among health professional of Gimbi town 
in Ethiopia by Tesfaye, Gebeyehu and Likisa (2014). The study revealed a 100% 
awareness among the subjects, 54.2% could identify PEP drug regimens, and 83.3% had 
a positive attitude towards the use of PEP. Half the subjects had previous HIV risk 
exposures but only 16.7% of them sought PEP services. Tesfaye et al (2014:1); therefore, 
concluded that health professionals of Gimbi had adequate knowledge and a positive 
attitude towards HIV PEP, however, PEP uptake remained low even with the high rate of 
risky exposures experienced (Tesfaye et al 2014:1). 
 
Monera and Ncube (2014:1) concur that the appropriate use of Post-Exposure 
Prophylaxis is an important strategy in the prevention of HIV infection in exposed health 
care workers. They conducted a cross-sectional survey amongst 131 health care workers 
in a Zimbabwean referral hospital, where they assessed knowledge, attitudes and 
practices on occupational HIV Post-Exposure Prophylaxis. Results revealed poor 
knowledge of occupational HIV PEP in the majority of the respondents, with 65% of the 
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subjects scoring less than 50% on knowledge and only 5% scoring above 75%. 
Respondents were however found to have positive attitudes toward HIV PEP, with 93% 
expressing willingness to undergo PEP in case of exposure. Of the 131 subjects, 49 had 
previously been potentially exposed but only 45% of them sought PEP, indicating low 
uptake. 
 
A descriptive cross-sectional study among 129 primary health care workers was 
conducted by Uzochukwu, Sibeudu, Ughasoro, Okwuosa and Onwujekwe (2014). The 
study evaluated knowledge, attitude and practice of HIV PEP. In this study, findings 
revealed that 86% of the respondents had knowledge, 92.9% agreed that PEP reduces 
chances of infection and 29% treated themselves with PEP after exposure while the 
remaining 71% were not serious with the treatment. From these findings, a conclusion 
was made that a gap existed between the knowledge, which was impressive, or attitude, 
which was also favourable, and the practice of PEP among the health care workers 
(Uzochukwu et al 2014:4-6). 
 
Aminde, Takah, Noubiap, Tingdon, Ngwasiri, Jingi, Kengne and Dzudie (2015) conducted 
a cross-sectional study amongst clinical medical students in Cameroon where they 
assessed knowledge on HIV PEP, practices in response to occupational exposure and 
the determinants of good knowledge on PEP. In this study, 89% of the 154 respondents 
were found to have heard about PEP, 61.7% had moderate knowledge and 32.5% had 
poor knowledge about PEP. A conclusion was therefore made that there was a significant 
knowledge and practice gap on PEP indicating the need to introduce and strengthen 
training modules on workplace safety (Aminde et al 2015:2, 3, 17).  
 
Aminde, Takah, Dzudie, Bonko, Awungafac, Teno, Mbuagbaw and Sliwa (2015) 
conducted another cross-sectional study in Cameroon which involved 80 nurses, where 
knowledge and practice of PEP by nurses was assessed. Results showed that 73.7% of 
the respondents had poor knowledge about HIV PEP, 85% considered themselves to be 
at risk of occupational exposure of HIV, with 67.5% having been exposed in the past. But 
only 18.9% of those exposed received PEP. Aminde et al (2015:3) then concluded that 
knowledge and practice of HIV PEP amongst nurses in Cameroon was low. 
 
Ncube, Meintjes and Chola (2014:2) state that “studies have demonstrated a lack of 
awareness of non-occupational PEP in the general population.” The authors conducted 
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a descriptive cross-sectional study aimed at evaluating knowledge and attitudes towards 
availability of, access to and use of nPEP among 169 medical students. 28% of the 
respondents reported knowledge of nPEP, of the 28%, 67% reported hearing about it 
from lecturers while 1% reported hearing about it from their partners. The subjects had a 
positive attitude towards nPEP even though their knowledge was poor. 
Generally findings in the African studies revealed high HIV exposures and high 
awareness of PEP. Knowledge was found to be fair and there seems to be an overall 
positive attitude towards use of PEP. This could be owed to the high prevalence of HIV 
2.4.3 Implication of the findings  
 
The majority of the studies reviewed revealed that knowledge regarding HIV PEP 
amongst health care workers is very poor. These are people who are responsible for 
providing the general population with HIV PEP services should the need arise. This 
findings invokes feelings of worry, who then provide HIV PEP services to the public when 
the health care providers themselves have deficient knowledge? Adequate knowledge 
and practices on HIV PEP among health care providers are crucial for prevention of HIV 
(Aminde et al 2015:2). Generally, attitudes toward use and prescription of HIV PEP are 
favourable; however, most health care settings seem to have low uptake of PEP even 
with the evident reported high risk exposures to HIV. 
 
The findings on knowledge in Africa are profoundly worrying seeing as Africa is the one 
continent mostly affected by the HIV pandemic and it is therefore the one region where 
Health Care workers would be expected to be conversant with issues pertaining to HIV 
prevention. Health Care Workers, being providers of the HIV PEP services, are 
responsible for disseminating information and education to the general population, not 
only about PEP but about all other measures of prevention. Their deficient knowledge or 
lack thereof consequently becomes detrimental to the health of their clients.  
 
All studies reviewed focus mainly on the Knowledge, attitude and use of PEP by health 
care professionals. The research design used in most of the studies reviewed used 
descriptive cross-sectional. This assisted the researcher to utilise descriptive cross-
sectional design for the study. Little is documented about the clients or people who are 
non-health care workers. This made the researcher to realise the need for conducting this 
study which focused on assessing knowledge, attitudes and utilisation of HIV PEP among 
adults in Roma, Lesotho in order to make recommendations for promoting awareness 
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and the use of HIV PEP among adults in Roma, Lesotho. The findings of this study will 
assist add to the body of knowledge regarding HIV PEP. The findings of the study will 
also assist in finding ways of increasing information and utilisation of HIV PEP by the 
clients especially in Lesotho where HIV prevalence and incident rates are still high.   
 
2.5 CONCLUSION 
This Chapter presented the search strategy used, appraisal of reviewed studies, a short 
discussion on HIV PEP as well as literature on knowledge, attitude and use of HIV PEP. 
Since studies on nPEP are scarce, the focus of literature review was mostly on 
occupational HIV PEP. The succeeding Chapter discusses the methodology and 
research design used to conduct the study.  
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CHAPTER 3: RESEARCH DESIGN AND METHODOLOGY 
 
3.1 INTRODUCTION 
The previous chapter gave a detailed discussion on relevant literature reviewed regarding 
HIV PEP. The findings from literature also guided the research design and methodology 
for this study. This chapter discusses the methodology that was used to conduct the 
study. The discussion is structured around the research approach, design, setting and 
population, sampling, ethical considerations, data collection process and management 
as well as data analysis. 
3.2 RESEARCH APPROACH 
According to Polit and Beck (2012:739), a quantitative research approach is one that 
investigates observable occurrences that are subject to precise measurement and 
quantification. According to Thomas (2013:116), a quantitative research deals with 
numbers. The researcher felt that the quantitative approach would be best suited for this 
study as it is to deal with data in numeric form and utilise variables that are measurable, 
such as looking at the number of adults who have accessed HIV PEP and how much they 
know about HIV PEP.  
 
3.3 RESEARCH DESIGN 
Brink, van der Walt and van Rensburg (2014:96) define research design as a set of logical 
steps that the researcher takes in order to answer the research question. Babbie and 
Mouton (2011:74-75) define a study design as a plan or blue print of how one aims to 
conduct the research and; it focuses on the end product, logic of the research and point 
of departure. For this study, the researcher employed a cross-sectional, descriptive, non-
experimental design to assess knowledge, attitudes and utilisation of HIV PEP among 
adults in Roma, Lesotho. De Vos, Strydom, Fouche and Delport (2013:155,156) 
described non-experimental designs as designs that are mainly used in descriptive 
studies in which the units selected to participate in the study are measured on all relevant 
variables at a specific time, and there is no manipulation of variables. In support of this 
Brink, van der Walt & van Rensburg (2014:112) state that a non-experimental research 
aims to describe an occurrence and to explore and explain how variables are related, 
without any intervention whatsoever. Furthermore, Brink et al (2014:112) continue to 
define a descriptive study design as one that describes variables so as to answer the 
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research question. This study was non-experimental and descriptive in that the 
researcher did not  in any way manipulate variables but just provided a description of how 
much adults know about HIV PEP, how many have accessed HIV PEP and what their 
attitudes are regarding HIV PEP.  
3.4 RESEARCH METHOD 
Research method refers to the steps, procedures, principles and strategies for collecting 
and analysing the data in a research investigation (Rees 2011:244). This section addresses 
study setting, sampling, data collection and data analysis.  
3.4.1 Setting and population 
 
3.4.1.1 Setting 
Polit and Beck (2012:743) define research setting as “the physical location and conditions 
in which data collection takes place in a study”. The fieldwork of the study was carried out 
at St Joseph’s Hospital, in an area called Roma in the district of Maseru, Lesotho. St 
Joseph’s, the only hospital in Roma, is a Catholic hospital that services about 6% 
(120 000) of Lesotho’s population. Roma has a population of about 11612 (Lesotho 
Bureau of Statistics) Roma is situated about 34 kilometres south-east of Maseru, the 
capital of Lesotho. HIV prevalence in Maseru is 27% (Mugomeri, Senauoane, Ruhanya, 
Chino’mbe & Nyandoro 2015: 1). Roma also hosts the country’s national university, 
several primary and high schools and a nursing college. 
 
3.4.1.2 Population 
Polit and Beck (2012:273) define population as “the entire aggregation of cases in which 
a researcher is interested”. According to Parahoo (2014:411) population is defined as the 
entire set of individuals or objects having some common characteristics, from which data 
are collected. In other words, population is a complete set of units/elements that have 
some common characteristics that the researcher is interested in (Brink et al, 2014:131). 
According to Polit and Beck (2012:744), target population is the entire population in which 
a researcher is interested and to which the study results will be generalised. The target 
population of this study comprised of adult (male and female) out-patients who are not 
health care workers, at St Joseph’s Hospital in Roma.  
 
 
 
 26 
 
3.4.2 Sampling 
 
Sampling is defined as the process of selecting a portion of the population, so that 
conclusions/deductions about the entire population can be made (Polit & Beck, 
2012:275). The researcher used stratified random sampling to select the 
elements/respondents. This sampling technique has an advantage of yielding a more 
representative sample as it allows each element in the population an equal probability of 
being selected (Polit & Beck, 2012:280). The researcher selected every second adult out-
patient she met, and the sample was stratified according to gender to ensure 
representation of both the male and female population and thereby avoided sampling 
bias. However, attempts to get as many male respondents as female respondents failed 
as most outpatients were female. 
 
A sample is a subset of the population that is selected to participate in a research study 
(Polit & Beck 2012:750). The researcher used the sample size calculator from Survey 
Monkey Inc. to calculate the study sample. A confidence interval/margin of error of plus-
or-minus (+-) 10 and the confidence level of 95% were used.  
 
The formula used is as follows:  
𝑆𝑎𝑚𝑝𝑙𝑒 =
𝑧2 × 𝑝(1 − 𝑝)
𝑒2
1 +
𝑧2 × 𝑝(1 − 𝑝)
𝑒2𝑁
 
 
Where: 
Z is the Z-value/score, which for a confidence level of 95% is 1.96, this value is a constant. 
p is the standard of deviation, which in this case (expressed as a decimal) = 0.5. 
e is the confidence interval which here, (expressed as a decimal) = 0.1. 
N is the total population of Roma =11612 
 
Therefore sample size =  
1.962×0.5(1−0.5)
0.12
1+
1.962×0.5(1−0.5)
0.12×11612
 
       
    =  
1.928×1−1.928×0.5
0.01
1+
1.928×1−1.928×0.5
0.01×11612
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       = 
1.928−0.964
0.01
1+
1.928−0.964
116.12
 
 
       = 
0.964
0.01
1+
0.964
116.12
 
 
       = 
96.4
1+0.0083
 
 
       = 
96.4
1.0083
 = 95.6 = 96    
  
3.4.2.1 Inclusion criteria 
 Non-health care workers 
 Out-patients 
 18 years and above 
 
3.4.2.2 Exclusion criteria 
 Health care workers  
 Inpatients  
 Below 18 years. 
 
3.4.3 Ethical considerations  
 
Polit and Beck (2012:727) define ethics as “a system of moral values that is concerned 
with the degree to which research procedures adhere to professional, legal, and social 
obligations to the rights and interests of respondents”. This following are ethical aspects 
which were considered for this study. 
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3.4.3.1 Informed and non-coerced consent 
The researcher has to ensure that respondents are not coerced into taking part, the 
participant must decide voluntarily whether or not to participate (Brink et al 2014:40). Polit 
and Beck (2012:157) state that the participant must have adequate information about the 
study, understand such information and decide whether to participate or not of their own 
free will. Before signing the consent form, respondents were informed about the purpose 
of the study, the procedures involved and how the findings of the study will be used. 
Participation was not coerced by any means whatsoever, and respondents were 
guaranteed anonymity, confidentiality of records and assurance that they maintained the 
right to refuse to participate or to withdraw from the study at any time, should they feel 
the need to, without any prejudice, penalty or castigation. 
 
3.4.3.2 Privacy and confidentiality 
The most inviolable means of protecting confidentiality is anonymity, especially when the 
researcher is unable to link respondents to their data (Polit & Beck 2012:162). Codes 
were used, for example “R1” for first respondent, instead of real name of the respondents. 
All personal information that may be a threat to confidentiality such as patient hospital 
number or identity number was not requested. All other information obtained was strictly 
confidential and anonymous. To enhance anonymity, data collection was not primarily 
face-to-face; respondents dropped the completed data collection tool in boxes placed 
strategically at the hospital. For those respondents who for some reason required the 
researcher to assist in completing the questionnaire confidentiality was guaranteed. 
 
The real name of the hospital was used because the information does not have any 
implications to the hospital; the hospital was just used to access the population. 
 
3.4.3.3 Acknowledgement of data sources 
According to Brink et al (2014:43), a researcher must respect the scientific community by 
protecting the integrity of scientific knowledge. Plagiarism was avoided at all cost. 
Thomas (2013:86-87) defines plagiarism as “the submission of formal assessment of an 
assignment that incorporates without proper citation or acknowledgement by means of 
an accepted referencing standard, the intellectual property or work of a third party”. All 
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data obtained from documents and records was acknowledged and citations and 
references made accordingly.  
 
3.4.3.4 Permission from authorities and gatekeepers 
Researchers may not be objective in their risk/benefit assessment or in their efforts to 
protect the rights of the research subjects (Polit & Beck 2012:165). For this reason, the 
ethical dimensions of a study must be subjected to external review. The proposal was 
therefore submitted to the Research and Ethics committee of the University of South 
Africa (UNISA), College of Human Sciences (CHS) for approval and ethical clearance. 
Permission was also obtained from the Ministry of Health and from St Joseph’s Hospital 
management to undertake the study. Outpatient department staff were also sensitised to 
the study, following which permission was sought and granted prior data collection.  
 
3.4.3.5 Principle of respect for human dignity 
Prospective respondents have the right to full disclosure and to decide whether to take 
part in a study without being prejudiced (Polit & Beck 2012:154). The researcher 
disclosed all the aspects of the study to respondents, their right to refuse participation 
and possible risks. The researcher ensured that rapport was well established before 
embarking on data collection, and sensitive questions were addressed in a manner that 
did not violate human dignity while also ascertaining that the true meaning was not lost. 
There were no promised personal gains/benefits for the respondents, they took part out 
of their volition and did not incur any financial costs. 
 
3.4.3.6 Benefits from the study 
According to Polit and Beck (2012:152), “Human research should be intended to produce 
benefits for respondents or, a situation that is common for others.” The researcher hopes 
that the findings will benefit the respondents and the Basotho nation as a whole because 
it will bring into awareness the need for mobilisation of PEP services to fight the HIV 
pandemic. 
 
 
3.4.4 Data Collection  
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Data collection refers to the process of gathering information to address a research 
problem (Polit & Beck 2012:725).This Section addresses the methods and procedures 
used in gathering information relevant to the research purpose. Data collection was 
conducted following the ethical approval by the Higher Degrees Committee of the 
Department of Health Studies at the University of South Africa (Annexure 1). Approval 
was also granted by the Lesotho Ministry of Health Ethics Committee (Annexure 2), as 
well as the Management of St Joseph’s Hospital (Annexure 3). 
 
3.4.4.1 Data collection instrument development 
The study employed a structured questionnaire (Annexure 5A), which was translated to 
Sesotho for better clarity and understanding (Annexure 5B). A questionnaire is a 
document that is used to gather self-report data through self-administration of questions 
(Polit & Beck 2012:740). In addition to being a primary means of data collection in 
quantitative studies (Polit & Beck 2012:305), as compared to other means of data 
collection, a questionnaire was the tool of choice in this study for the following reasons:  
 It is less time consuming  
 It is cost-effective  
 It assures greater anonymity 
 Absence of interviewer means no interviewer bias 
 
The questionnaire was developed to elicit responses relevant to the aim of the study, 
which was to obtain information regarding knowledge, attitudes and utilisation of HIV PEP 
amongst adults. The formulation of questions was influenced by pre-testing outcomes, 
the objectives of the study and the reviewed literature. The questions included multiple 
choice questions, true or false questions and Likert type scale questions. Ambiguity and 
response biases were avoided and sensitive questions were worded cautiously. The 
questionnaire is composed of four sections. Section A focused on demographic data, 
section B focused on knowledge regarding HIV PEP, section C focused on attitude 
towards HIV PEP while section D focused on use of HIV PEP. The questionnaire was 
piloted with 10 individuals who met the inclusion criteria but were not part of the final 
sample. 
 
3.4.4.2 Validity and Reliability of the questionnaire 
 31 
 
A researcher needs to consider both validity and reliability when selecting a research 
instrument, there is no point in using an instrument that is not valid. However reliable it 
may be, by the same token, if an instrument is valid but the measurements are not 
consistent, it is of no use (Brink et al 2014:171). 
3.4.4.2.1 Validity 
In the context of research, validity is the approximate truth of an inference (Shadish & 
colleagues), cited in Polit and Beck (2012:236). A conclusion made in a research could 
be wrong because of threats to validity, therefore when researchers introduce design 
features they have to strengthen the validity of the inference (Polit & Beck 2012:236). 
Polit and Beck (2012:336) further continue to define validity as the degree to which an 
instrument measures what it is supposed to measure. Validation functions to build 
sufficient evidence from which validity can be inferred and the greater the amount of 
evidence, the more sound the inference (Polit & Beck 2012:336). Brink et al (2014:165) 
show that an instrument can be the source of several factors that can cause random 
errors and affect data quality. Such factors include: unclear directions, unclear questions, 
inadequate sampling of items, wrong format, wording and order of questions (Brink et al 
2014:165). If there are errors in the instrument, respondents may not know how to 
respond to items and end up guessing the answers rather than giving true answers. Brink 
et al (2014:165) define instrument validity as the degree to which an instrument measures 
what it is supposed to measure. To ensure validity of the data collection tool, the 
researcher has aligned the questions with the objectives, the research questions and the 
reviewed literature. The tool was also pre-tested on a few individuals who were not 
included in the final sample, following which errors were addressed. Following 
corrections, the tool was peer reviewed and then given to a PhD fellow for final review. 
3.4.4.2.2 Reliability 
According to Polit and Beck (2012:331), in a quantitative study, an instrument is said to 
be reliable if it is accurate and consistent in the way it measures the target attribute. In 
support of this, Thomas (2013:138) defines reliability as the extent to which an instrument 
will give the same result on different occasions. If there is less variation produced when 
an instrument is used in repeated measurements it has higher reliability, meaning it is 
stable, consistent or dependable (Polit & Beck 2012:331).  
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To address the issue of reliability, the confidence level of 95% was used when calculating 
sample size to ensure that the sample is large enough to inherently reduce sample errors. 
The cronbach’s alpha was 0.9. The questions were aligned with the objectives of the 
study. The tool was pre-tested on a few individuals, who were not included in the study, 
and changes were then made accordingly. Any ambiguity was corrected and questions 
deemed unnecessary were modified or deleted from the tool.  
 
3.4.4.3 Data collection approach and method 
The researcher first prepared a data collection plan for efficiency. She then personally 
disseminated the data collection tools. For those consenting respondents who, for 
whatever reason (e.g. illiteracy), were unable to complete the questionnaire, the 
researcher assisted. During data collection, the researcher was always within reach to 
supervise, assist and address concerns and to clarify any misunderstandings. 
 
Respondents completed the questionnaires and then dropped them in a box outside the 
consultation rooms, where the researcher later collected them. Data collection took place 
from April to June 2016. 
 
3.4.5 Data management and analysis 
 
This Section discusses how data was stored, organised and analysed 
 
3.4.5.1 Data management 
Upon collection, all data were kept under lock and key for safety. The questionnaires 
completed and returned were 96, giving a response rate of 100%. Data were then 
reviewed for completeness and legibility, and data gaps were addressed (Polit & Beck 
2012:463). Language translations were made where necessary.  
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3.4.5.2 Data analysis 
Data analysis is a systemic organization and synthesis of the research data (Polit & Beck 
2012:725). Grove, Burns and Gray (2013:46) define data analysis as a process that 
reduces, organises and gives meaning to the data.  
Data capturing and analysis were done with the computer programme “Statistical 
Package for the Social Sciences (SPSS) version 23”. Analysis was done using 
descriptive and inferential statistics. Polit and Beck (2012:379) stated that descriptive 
statistics is used to describe and synthesise data. Burns and Grove (2013:490) mention 
that descriptive statistics allows researchers to organise data in a way that gives meaning 
and insight. Descriptive statistical procedures such as tables, graphs and proportions 
were used to report and describe findings. This method of analysis was chosen because 
the research aimed at quantifying the knowledge, attitudes and utilisation of HIV PEP by 
adults in Roma.The responses from respondents were quantified. The levels of 
measurements used are ordinal and categorical and data were synthesised in order to 
calculate average, frequencies and percentages. 
3.5 CONCLUSION 
This Chapter presented the research methodology that was used in the study addressing 
study approach and design, setting and population and sampling. The chapter also 
detailed data collection approach used, development of questionnaire, piloting the 
questionnaire and administration of the research questionnaire. It further indicated how 
issues of validity and reliability and ethical considerations were addressed throughout the 
research study. Data analysis method was also highlighted. In the next Chapter, 
presentation and analysis of the collected data will be discussed.  
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CHAPTER 4: PRESENTATION OF RESULTS 
 
4.1 INTRODUCTION 
 
The previous chapter highlighted the research design, method of data collection and data 
analysis. This chapter presents the findings of the study. The data were analysed using 
the Statistical Package for Social Sciences (SPSS) version 23.0. The main Sections of 
the questionnaire were highlighted. The percentages in the tables and figures are 
presented as received from the data analysis software. Results were then presented in 
tables and charts, and interpretations were made. 
4.2 RESEARCH FINDINGS 
The main objectives of this study were to assess the knowledge of adults in Roma 
regarding HIV PEP following non-occupational exposure, to explore their attitudes 
regarding the use of PEP, to find out accessibility and utilisation of PEP services by the 
stated adults. The results have been organised around these objectives. 
 
4.2.1 Socio-demographic characteristics of respondents 
 
The socio-demographic characteristics of the respondents are described according to 
gender, age, marital status, educational qualification, religious background and 
occupation. 
 
4.2.1.1 Gender of the respondents 
Out of the 96 respondents, 44.8% (n=43) were males while 55.2% (n=53) were females 
as depicted in Figure 4.1 below. There were more females than males. 
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Figure 4.1: Gender of the respondents (N=96) 
 
4.2.1.2 Age of the respondents 
Figure 4.2 depicts the ages of the respondents. According to the results, the most 
represented age group distribution was 18-24 years with 30.2% (n=29), followed by 35-
39 years with 19.8% (n=19). Age groups 25-29 and 40 years and above came third with 
a representation of 17.7% (n=17) each and lastly 30-34 years with 14.6% (n=14). 
 
 
Figure 4.2: Ages of the respondents (N=96) 
 
19.8% 
17.7% 
55.2% 
30.2% 
44.8% 
17.7% 
14.6% 
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4.2.1.3 Marital status of the respondents 
50% (n=48) of the respondents were single, 31.3% (n=30) were married, 9.4% (n=9) 
widowed, 5.2% (n=5) divorced and 4.2& (n=4) separated as depicted in Figure 4.3 below. 
A greater number of the respondents were single, followed by those who were married. 
 
 
Figure 4.3: Marital status of the respondents (N=96) 
 
4.2.1.4 Educational qualifications of the respondents 
Figure 4.4 depicts the educational qualifications of the respondents. A large number of 
the respondents had some educational qualification, with 38.5% (n=37) respondents 
holding a Cambridge Overseas School Certificate (COSC) or equivalent, followed by 
15.6% (n=15) with Junior Certificate (JC), another 15.6% (n=15) with Diploma, 14.6% 
(n=14) with Primary School Leaving Examination (PSLE) certificate, and 6.3% (n=6) with 
a university degree. 9.4% (n=9) of the respondents had no educational qualification. No 
subjects held higher degrees. 
 
50.0% 
31.3% 
5.2% 
4.2% 9.4% 
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Figure 4.4: Educational qualifications of the respondents (N=96) 
4.2.1.5 Religious background of the respondents 
Figure 4.5 below shows religious background of the respondents. 89.6% (n=86) of the 
respondents reported to be Christians, 6.3% (n=6) were ancestral worshippers and 2.1% 
(n=2) were Muslims. 1.0% (n=1) indicated other and another 1.0% did not respond to the 
question. The sample was mainly Christian. 
 
 
 
Figure 4.5: Religious background of the respondents (N=96) 
 
6.3% 
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1.0% 
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4.2.1.6 Occupations of the respondents 
The Figure below presents the different occupations of the respondents. Study results 
showed that 54.2% (n=52) of the respondents were unemployed, 9.4% (n=9) were high 
school or tertiary students, 12.5% (n=12) reported to be self-employed and the rest were 
employed in either the formal or informal sectors as follows: 4 (4.2%) teachers, 4 (4.2%) 
security guards, 3 (3.1%) cashiers, 3 (3.1%) maids and 1% (n=1) each of the following: 
bank teller, barber, cook, court clerk, factory worker, herdboy, mechanic, policeman and 
taxi driver. 
 
More than half of the respondents were unemployed. Those who were employed, the 
majority were self-employed, followed by those employed in the informal sector, and the 
last group were the professionals. Students were also represented.  
 
 
 
 
 
Figure 4.6: Occupations of the respondents (N=96) 
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4.2.2 Knowledge regarding HIV PEP  
 
This section presents data collected on assessment of knowledge on HIV PEP as per a 
question. The questions were mostly multiple-choice questions with the following options: 
True, False or I do not know. All respondents were requested to answer the questions on 
knowledge, including those who were hearing of HIV PEP for the first time during data 
collection. 
 
4.2.2.1 HIV PEP awareness 
Figure 4.7 below depicts the respondents’ responses to the question “Have you ever 
heard of HIV Post-Exposure Prophylaxis?”. Out of the 96 respondents, 35.4% (n=34) 
reported to be aware of HIV PEP while 64.6% (n=62) were hearing of it for the first time 
during data collection. Majority of the respondents were not aware of PEP. 
 
 
 
 
 
Figure 4.7: HIV PEP awareness (N=96) 
 
4.2.2.2 Sources of HIV PEP information 
Out of the 34 respondents who reported to have heard of HIV PEP, 44.7% (n=15) had 
their source of information as a Health Facility, 14.7% (n=5) radio, 11.8% (n=4) 
friend/relative, another 11.8% (n=4) written source, and 5.9% (n=2) each of the following: 
television, internet and training. This information is shown in Figure 4.8 below. 
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Figure 4.8: Source of information on HIV PEP (n=34) 
 
Of those respondents who were PEP-aware, majority learnt of it from a Health facility.  
 
4.4.2.3 Views related to the use of HIV PEP 
Respondents have different views regarding the use of PEP. Table 4.2 below presents 
responses to different statements in relation to PEP 
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Table 4. 1 Views related to the use of HIV PEP (knowledge) (N=96) 
 
Statement True  False Don’t 
Know 
Missing Total 
PEP refers to ARV 
medication used to prevent 
HIV infection 
30.2% 
(n=29)  
13.5% 
(n=13) 
56.3 
(n=54) 
 100% (n=96) 
PEP is medication given to 
HIV positive individuals after 
being tested 
25.0% 
(n=24) 
11.5% 
(n=11) 
63.5% 
(n=61) 
 100% 
(n=96) 
PEP is given to HIV negative 
individuals to prevent 
acquisition of HIV following 
exposure to infected body 
fluids 
22.9% 
(n=22) 
14.6% 
(n=14) 
62.5% 
(n=60) 
 100% 
(n=96) 
PEP is taken for one week 
only 
6.3% 
(n=6) 
14.6% 
(n=14) 
79.2% 
(n=76) 
 100% 
(n=96) 
HIV negative individuals do 
not need to take PEP 
31.3% 
(n=30) 
9.4% 
(n=9) 
59.4% 
(n=57) 
 100% 
(n=96) 
PEP is for nurses and 
doctors only 
3.1% 
(n=3) 
38.5% 
(n=37) 
58.3% 
(n=56) 
 100% 
(n=96) 
PEP can be started 5 days 
post exposure 
6.3% 
(n=6) 
14.6% 
(n=14) 
79.2% 
(n=76) 
 100% 
(n=96) 
One cannot be given PEP if 
they have been exposed to 
HIV through consensual 
sexual intercourse 
15.6% 
(n=15) 
16.7% 
(n=16) 
66.7% 
(n=64) 
1.0% 
(n=1) 
100% 
(n=96) 
PEP is taken for 28 days only 15.6% 
(n=15) 
9.4% 
(n=9) 
74.0% 
(n=71) 
1.0% 
(n=1) 
100% 
(n=96) 
PEP is a lifelong treatment 14.6% 
(n=14) 
21.9% 
(n=21) 
63.5% 
(n=61) 
 100% 
(n=96) 
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PEP medication has no side 
effects 
8.3% 
(n=8) 
11.5% 
(n=11) 
80.2% 
(n=77) 
 100% 
(n=96) 
PEP can be used as a primary 
means of HIV prevention 
27.1% 
(n=26) 
10.4% 
(n=10) 
62.5% 
(n=60) 
 100% 
(n=96) 
One needs to be tested for 
HIV before they can receive 
PEP 
39.6% 
(n=38) 
3.1% 
(n=3) 
57.3% 
(n=55) 
 100% 
(n=96) 
PEP can cure HIV 14.6% 
(n=14) 
35.4% 
(n=34) 
50.0% 
(n=48) 
 100% 
(n=96) 
Frequent use of PEP can 
cause drug resistance 
14.6% 
(n=14) 
16.7% 
(n=16) 
68.8% 
(n=66) 
 100% 
(n=96) 
 
 
Table 4.1 presents the following:  
In response to the statement “PEP refers to antiretroviral medication used to prevent HIV 
infection” 54 (56.3%) of the 96 respondents did not know, 29 (30.2%) selected the correct 
answer (True), and 13 (13.5%) selected the wrong answer (False). Even though 34 out 
of 96 previously reported to be aware of PEP some of them still did not know what PEP 
was, this is supported by the number (29) of the respondents who selected the correct 
answer.  
 
In response to the statement “PEP is medication given to HIV positive people after being 
tested” 63.5 % (n=61) did not know if the statement was true or false, 25.0% (n=24) 
selected the wrong option (True) and 11.5% (n=11) selected the correct option (False). 
The question was poorly answered, with only 11.5% selecting the correct answer.  
 
In response to the statement “PEP is given to HIV negative individuals to prevent 
acquisition of HIV following exposure to HIV infected body fluids” 62.5 % (n=60) did not 
know if the statement was true or false, 22.9% (n=22) selected the correct option (true) 
and 14.6% (n=14) selected the wrong option (false). With only 22.9% of the respondents 
selecting the correct answer, this shows that even those who previously reported to be 
PEP aware did not know what PEP was. 
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When responding to the statement “PEP is taken for one week only” 79.2% (n=76) did 
not know if the statement was true or false, 14.6% (n=14) selected the correct option 
(true) and 6.3% (n=6) selected the wrong option (true). The statement was poorly 
addressed with only 14.6% selecting the correct answer. For the general population, 
knowledge of duration of PEP is not essential but it is important so that potential PEP 
seekers can be prepared.  
 
In response to the statement “HIV negative people do not need to take PEP” 59.4% 
(n=57) did not know if the statement was true or false, 31.3% (n=30) selected the wrong 
option (true) and 9.4% (n=9) selected the correct option (false). Only 9.4% of the 
respondents selected the correct option. 
 
In response to the statement “PEP is for nurses and doctors only” 58.3% (n=56) did not 
know if the statement was true or false, 38.5% (n=37) selected the correct option (false) 
and 3.1% (n=3) selected the wrong option (true). Less than half the respondents selected 
the correct option. It is imperative that people know that everyone can access PEP 
services when needed. 
 
When responding to the statement “PEP can be started 5 days after being exposed to 
HIV” 79.2% (n=76) did not know if the statement was true or false, 14.6% (n=14) selected 
the correct option (false) and 6.3% (n=6) selected the wrong option (true). The question 
was poorly answered, with only 14.6% of the subjects knowing the correct answer. It 
means that if the other 85.4% were to be in a position that required them to request PEP, 
there would be a delay with dire consequences. 
 
In response to the statement “One cannot be given PEP if they have been exposed to 
HIV through consensual sexual intercourse” 66.7 % (n=64) did not know if the statement 
was true or false, 16.7% (n=16) selected the correct option (False) and 15.6% (n=15) 
selected the wrong option (True). 1.0% (n=1) did not address the question. 
With only 16.7% of the respondents knowing the correct answer, it means that the others, 
even if PEP-aware, would not seek PEP services following exposure through consensual 
sexual activities, leaving themselves at the mercy of “chance”. 
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In response to the statement “PEP is taken for 28 days only” 74.0% (n=71) did not know 
if the statement was true or false, 15.6% (n=15) selected the correct option (True) and 
9.4% (n=9) selected the wrong option (False). One percent 1% (n=1) did not address the 
question. The question was also poorly addressed. Although important, it is not essential 
to know the duration of PEP treatment as one would get this information when they are 
started on the treatment. 
 
In response to the statement “PEP is a lifelong treatment” 63.5 % (n=61) did not know if 
the statement was true or false, 21.9% (n=21) selected the correct option (False) and 
14.6% (n=14) selected the wrong option (True). With only 21.9% of the respondents 
knowing the correct answer, the question was poorly answered. Although it is important 
to know the duration of PEP, it is not essential. However others may be deterred from 
seeking PEP services when exposed for fear of taking a lifelong treatment and thereby 
placing themselves at risk of acquiring the HIV infection. 
 
For the statement “PEP medication has no side effects” 80.2% (n=77) did not know if the 
statement was true or false, 11.5% (n=11) selected the correct option (False) and 8.3% 
(n=8) selected the wrong option (True). The question was also poorly answered with just 
11.5% having selected the correct option. Although important, the information regarding 
ARV side effects is not essential as one would get it at the health facility when started on 
the treatment. It might however be of benefit to the exposed individual to know what to 
expect and therefore be better prepared. 
 
In response to the statement “PEP medication can be used as a primary means of HIV 
prevention” 62.5 % (n=60) did not know if the statement was true or false, 27.1% (n=26) 
selected the wrong option (True) and 10.4% (n=10) selected the correct option (False).  
With only 10.4% disagreeing with this statement, it means that the other 89.6% are still 
not well informed with regard to HIV prevention measures. 
 
In response to the statement “One needs to be tested for HIV before they can receive 
PEP” 57.3% (n=55) did not know if the statement was true or false, 39.6% (n=38) selected 
the correct option (True) and 3.1% (n=3) selected the wrong option (False). Only 39.6% 
gave the correct response, leaving the other 60.4% in the dark. It is important for potential 
PEP service seekers to know that they would need to be tested prior PEP prescription, 
so that they can be better prepared when they go to seek the services.  
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When addressing the statement “PEP can cure HIV” 50.0% (n=48) did not know if the 
statement was true or false, 35.4% (n=34) selected the correct option (False) and 14.6% 
(n=14) selected the wrong answer (True). The fact that only 35.4% of the respondents 
selected the correct option is an indication that the rest of the respondents still have an 
inkling that HIV can be cured. 
 
In response to the statement “Frequent use of PEP can cause drug resistance” 68.8% 
(n=66) did not know if the statement was true or false, 16.7% (n=16) thought it was false 
and only 14.6% (n=14) selected the correct option (True). Only 14.6% of the respondents 
knew the truth of the statement. It is important that people know this so that exposure is 
avoided at all costs. Lack of this knowledge might influence careless behaviour among 
PEP aware individuals.  
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4.2.3 Attitude towards HIV PEP 
This section presents data on assessment of attitude towards HIV PEP.  
 
4.2.3.1 Views related to HIV PEP 
 
Table 4.2: Views related to PEP (attitude) (N=96) 
Statement SD D U A SA Total 
PEP is an important measure of HIV prevention 12.5% 
(n=12) 
15.6% 
(n=15) 
58.3% 
(n=56) 
6.3% 
(n=6) 
7.3% 
(n=7) 
100% 
(n=96) 
Everyone should have access to PEP 26.0% 
(n=25) 
29.2% 
(n=28) 
42.7% 
(n=41) 
0.0% 
(n=0) 
2.1% 
(n=2) 
100% 
(n=96) 
PEP can reduce the likelihood of HIV infection 28.7% 
(n=27) 
7.3% 
(n=7) 
58.3% 
(n=56) 
2.1% 
(n=2) 
4.2% 
(n=4) 
100% 
(n=96) 
PEP can help reduce new HIV infections 18.8% 
(n=18) 
 
14.6% 
(n=14) 
57.3% 
(n=55) 
8.3% 
(n=8) 
1.0% 
(n=1) 
100% 
(n=96) 
Key: 
SD – Strongly Disagree 
D - Disagree 
U - Undecided 
A - Agree 
SA – Strongly Agree 
 
Table 4.2 presents the following: 
In response to the statement “PEP is an important measure of HIV prevention” 58.3% 
(n=56) were undecided about the statement, 15.6% (n=15) disagreed with the statement, 
12.5% (n=12) strongly disagreed, 7.3% (n=7) strongly agreed and 6.3% (n=6) agreed. 
Responses in this question give an impression that respondents are undecided or have 
a vague idea about HIV PEP and thereby having neither a negative nor a positive attitude 
towards HIV PEP. 
 
In response to the statement “Everyone should have access to PEP” 42.7% (n=41) were 
undecided about the statement, 29.2% (n=28) disagreed with the statement, 26.0% 
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(n=25) strongly disagreed, 2.1% (n=2) strongly agreed. Most responses (55.2%) negate 
this statement, suggesting a negative attitude towards access to HIV PEP. 
 
When addressing the statement “PEP can reduce the likelihood of HIV infection” 58.3% 
(n=56) were undecided about the statement, 28.1% (n=27) strongly disagreed with the 
statement, 7.3% (n=7) disagreed, 4.2% (n=4) strongly agreed and 2.1% (n=2) agree. 
While most respondents (58.3%) were undecided with regard to the statement, a slightly 
large number leaned towards disagreeing with the statement. 
 
In response to the statement “PEP can help reduce new HIV infections” 57.3% (n=55) 
were undecided about the statement, 18.8% (n=18) strongly disagreed with the 
statement, 14.6% (n=14) disagreed, 8.3% (n=8) agreed and 1.0% (n=1) strongly agreed. 
Once again the majority were undecided about the statement and a somewhat large 
proportion of the subjects inclined towards disagreeing. This is most likely a result of 
deficient knowledge. 
 
4.2.3.2 Consideration of use of HIV PEP 
Figure 4.9 presents answers to the question “If you had to, would you use HIV PEP?”. 
Results show that 90.6% (n=87) said they would use HIV PEP and 8.3% (n=8) would not. 
One percent (n=1), did not answer the question. Majority of the respondents would use 
HIV PEP if the need arose; this is a major indicator for a receptive attitude towards use 
of HIV PEP. 
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Figure 4.9 Consideration of use of HIV PEP (N=96) 
 
4.2.3.2.1 Reason for not considering use of HIV PEP 
Table 4.3 presents responses obtained from the 8 respondents who said they would not 
use HIV PEP to indicate why they would not. Majority, 87.5% (n=7) indicated fear of 
possible side effects. One participant (12.5%) did not respond. 
 
The small number that would not consider using HIV PEP for fear of possible side effects 
may lack information that would otherwise change their perspective. Individuals are 
unique with regard to the way they are affected by medication, some may suffer the side 
effects while others might not, and it is also important to understand and weigh the 
advantages against the disadvantages of taking the treatment.    
 
Table 4.3: Reason for not considering use of HIV PEP (n=8) 
Response Frequency Percentage 
Fear of possible side effects 
Missing 
7 
1 
87.5 
12.5 
Total 8 100.0 
 
4.2.3.3 General feelings regarding HIV PEP 
Figure 4.10 below presents responses obtained when respondents were asked to 
indicate how they generally felt about HIV PEP. Options were “it is important”, “none”, 
and “it is not important”. Majority, 57.3% (n=55) said it was important, 40.6% (n=39) 
selected none and none of the respondents thought it was not important. 2.1% (n=2) did 
not address the question. 
 
Even with the negative attitude indicated in the previous several questions, when asked 
how they generally felt about HIV PEP, respondents mostly said it is important. The 
response further indicated positive attitude about HIV-PEP. 
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Figure 4.10 General feelings regarding HIV PEP (N=96) 
 
4.2.3.4 Influence on general feelings regarding HIV PEP 
Table 4.4 presents responses obtained when respondents were asked to indicate what 
influenced their responses when asked to indicate their general feelings about HIV PEP. 
The Table shows that 39.6% (n=38) indicated religion as their influence while 5.2% (n=5) 
indicated that peers influenced their response. All 39 respondents (40.6%) who said they 
had no feelings regarding HIV PEP indicated that they were influenced by lack of 
knowledge, 9.4% (n=9) indicated it was just an opinion they had and 3.1% (3) indicated 
education received from a health centre as the influence.  Two respondents (2.1%) did 
not address the question. Responses were mainly influenced by religion. 
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Table 4.4: Influence on general feelings regarding PEP (N=96) 
Response given Frequency Percentage 
Religion 
Peers 
Education from a health center 
Lack of knowledge 
Just my opinion 
Missing 
38 
5 
3 
39 
9 
2 
39.6 
5.2 
3.1 
40.6 
9.4 
2.1 
Total 96 100.0 
 
Respondents who had no feelings regarding HIV PEP were influenced by lack of 
knowledge. Previous data suggest that had they been well informed, their responses 
might have been favourable towards HIV PEP, especially because majority indicated that 
they would use HIV PEP if they had to. 
 
4.2.4 Utilization of HIV PEP 
 
This section presents data on utilisation of HIV PEP. 
 
4.2.4.1 Previous HIV PEP use 
Table 4.5 presents responses obtained when respondents were asked if they had ever 
taken PEP. All 96 (100%) respondents reported to have never taken PEP. Use of PEP 
among the respondents is low or non-existent depending on the circumstances that might 
predispose to exposure.  
 
Table 4.5: Previous HIV PEP use (N=96) 
Response Frequency Percentage 
No 96 100.0 
Total 96 100.0 
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4.2.4.2 Knowledge of person who has taken HIV PEP 
Figure 4.11 presents responses obtained when respondents were asked if they knew 
anyone who has taken HIV PEP. 90.6% (n=87) said “no” while 9.4% (n=9) said “yes” they 
knew someone who had taken HIV PEP. The results here are a further indicator of low 
HIV PEP uptake not only among the respondents but also within their respective 
communities, also dependant on circumstances. 
 
 
Figure 4.11: Knowledge of person who has taken HIV PEP (N=96) 
 
Table 4.6 below presents reasons why HIV PEP was taken in 4.2.4.2 above. Out of the 
9 respondents who reported to have known someone who has taken HIV PEP, 44.4% 
(n=4) said they had HIV, 22.2% (n=2) said they had been exposed to blood from an 
infected person, 11.1% (n=1) said it was because they had unprotected sexual 
intercourse, another 11.1% (n=1) said it was because they had been raped and another 
11.1% (n=1) said it was to prevent mother to child transmission. 
 
These results suggest either misinformation or lack of knowledge for the 4 respondents 
who gave the reason “she had HIV” as an indication for PEP. They also suggest that 
some respondents do have an idea of PEP but only as PMTCT. 
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Table 4.6: Reason for taking PEP (n=9) 
Response Frequency Percentage 
Exposed to blood from an HIV infected person 
PMTCT 
She had HIV 
She was raped 
Unprotected sexual intercourse 
2 
1 
4 
1 
1 
22.2 
11.1 
44.4 
11.1 
11.1 
Total 9 100.0 
 
4.2.4.3 Knowledge of anyone who had tried to access HIV PEP but was unable to 
Figure 4.12 presents responses obtained when respondents were asked if they knew of 
anyone who had tried to access PEP but was unable to. Ninety five respondents (99%) 
selected “no” and only 1.0% (n=1) reported to know of such an individual (reason being 
she was told to open a rape case first as she was a rape victim).  
 
Even though majority (99.0%) of the respondents reported not to know of any individual 
who had tried but was unable to access PEP, the 1.0% (n=1) who did, revealed important 
information, that access might not be easy even for rape victims.  
 
 
Figure 4.12: Knowledge of anyone who had tried to access HIV PEP but was unable to (N=96) 
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4.2.4.4 Previous exposure to HIV 
Figure 4.13 below presents responses obtained when respondents were asked if they 
thought they had ever been exposed to potentially HIV-infected body fluids. Forty three 
respondents (44.8%) selected “I don’t know”, 43.8% (n=42) selected “no” and 10.4% 
(n=10) selected “yes”. 1.0% (n=1) did not respond to the question. 
 
Even though only 10.4% of the respondents reported exposure, the 43.8% that “did not 
know” calls for concern.  
 
 
Figure 4.13: Previous exposure to HIV (N=96) 
 
4.2.4.4.1 Actions taken after exposure to HIV 
From 4.2.4.4 above, the 10 respondents who reported to have been exposed to 
potentially infected body fluids were asked to indicate their actions following the exposure. 
Figure 4.14 below shows the responses they gave. Seven of them (70.0%) reported to 
have visited a health care facility, one (10.0%) washed the affected area and two (20.0%) 
did nothing. 
Majority of those who reported to have been previously exposed to potentially infected 
body fluids also reported to have visited a health care facility following the exposure. This 
indicates proactive behaviour towards prevention and health promotion. 
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Table 4.14: Actions taken following HIV exposure (n=10) 
 
4.2.4.4.2 Reasons for actions taken following the exposure 
The 10 respondents who reported to have been potentially exposed were asked to give 
reasons for the actions they took following the exposure, Table 4.7 below presents the 
reasons given. 40.0% (n=4) said they wanted to test for HIV, those who said they did 
nothing gave the following reasons; I didn’t know what to do (10.0%) and I didn’t think it 
was a big deal (10.0%). 10.0% (n=1) who washed the affected area said it was to remove 
the HIV, another 10.0% (n=1) each gave one of the following reasons: Everyone at home 
had HIV, My partner has HIV and To protect my life.  
 
Of the 7 who visited a health facility following exposure, 4 reported to have gone to test 
for HIV, this would suggest limited knowledge if they thought they would immediately 
sero-convert after being exposed.  For those that took no action following exposure and 
gave the reasons “I didn’t know what to do” and “I didn’t think it was a big deal” it might 
also be concluded that they had deficient knowledge.  
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Table 4.7: Reasons for actions following the exposure (n=10) 
 
Reasons given Frequency Percentage 
Everyone at home has HIV 
I did not know what to do 
I did not think it was a big deal 
My partner has HIV 
To protect my life 
To remove the HIV 
To test for HIV 
1 
1 
1 
1 
1 
1 
4 
10.0 
10.0 
10.0 
10.0 
10.0 
10.0 
40.0 
Total 10 100.0 
 
 
When asked if they thought the actions they took following exposure were correct, the 10 
respondents gave the responses shown in Table 4.8 below. 80.0% (n=8) selected “yes” 
while 20.0% (n=2) selected “no”. The two respondents that did nothing following potential 
exposure selected “no” when asked if they thought their actions were right.  
 
Table 4.8: Thoughts on actions taken following exposure (n=10) 
Response Frequency Percentage 
Yes 
No 
8 
2 
80.0 
20.0 
Total 10 100.0 
 
 
4.3 CONCLUSION 
 
This Chapter presented the results of the data analysis using pie charts, bar charts and 
tables. Descriptive statistics were employed using SPSS version 23.0. No comparisons 
were made between variables as the study aimed to describe knowledge, attitudes and 
utilisation of HIV PEP among adults. The next Chapter will discuss conclusions and 
limitations of the study as well as recommendations based on findings. 
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CHAPTER 5: DISCUSSION, CONCLUSIONS, LIMITATIONS AND 
RECOMMENDATIONS 
 
5.1 INTRODUCTION 
 
The previous Chapter presented results of the study. In the current Chapter, conclusions 
are drawn regarding knowledge, attitudes and utilisation of HIV PEP among adults in 
Roma, St Joseph’s hospital. The Chapter also discusses limitations of the study as well 
as recommendations. 
 
5.2 DISCUSSION OF RESEARCH FINDINGS 
 
The most significant research findings are summarised and interpreted in accordance 
with the main objectives of the study, which are:  
 To assess the knowledge of adults in Roma regarding HIV PEP following non-
occupational exposure, 
 To explore the attitudes of adults in Roma regarding the use of HIV PEP, 
 To assess utilisation of HIV PEP services by adults in Roma. 
 To determine accessibility to PEP services to adults in Roma, 
 To recommend strategies for promoting awareness and the use of PEP among 
adults in Roma, Lesotho 
 
5.2.1 Demographic data 
 
From the characteristics of the respondents, it can be deduced that there were more 
females (55.2%) than males (44.8%) in the study; nevertheless, 44.8% is still considered 
a fair representation for the male sex. Initially, there was a significant disproportion of 
gender distribution; however, the researcher extended the time allocated for data 
collection in an attempt to ensure a fair representation of both genders. 
 
The most represented age group distribution was 18-24 years with 30.2%, even so all 
other targeted adult age groups were represented. A greater number of the respondents 
were single, followed by those who were married. The sample was mainly Christian as is 
the Basotho population. 
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The sample included a spectrum of educational levels, from respondents with no 
education, those with primary education, those with high school education and those with 
tertiary education; however, no subjects held higher degrees.   
 
More than half of the respondents were unemployed, of those who were employed; the 
majority were self-employed, followed by those employed in the informal sector, and 
lastly, the professionals. Students were also represented. The sample was more 
representative of the peri-urban populations of Lesotho.  
 
5.2.2 Knowledge regarding HIV PEP  
 
PEP awareness was revealed to be very low among the respondents. Those at risk of 
exposure need to know of the existence of PEP so that infection can be prevented in 
cases of exposures. The few respondents who were PEP-aware learnt of it mostly from 
health facilities, indicating that there is some dissemination of information on PEP by 
Health professionals. The proportion of individuals who reported to be aware of PEP in 
the study was 35.4% (n=34). More or less similar results were reported in other studies, 
one such study was conducted by Mehta et al (2011:1) in New York, where only 36% of 
the respondents reported to be aware of PEP. This however differs from most studies 
done in Sub Saharan Africa among health care workers, where PEP awareness was 
found to be high, for instance one study conducted among health professionals in Ethiopia 
revealed a 100% awareness of PEP among the respondents (Tesfaye et al 2014). 
 
The questions addressing PEP duration were also poorly answered. For the general 
population, knowledge of duration of PEP is not essential but it is important so that 
potential PEP seekers can be better prepared. Only a few respondents knew that PEP 
can be accessed by everyone, no matter the mode of exposure, and not just health care 
professionals. A very large number of respondents also did not know that PEP should be 
started within 3 days of exposure, meaning that if they were to be in a position that 
required them to request PEP, there would be delays with detrimental consequences. It 
is imperative that people know that time is of the essence when it comes to PEP and that 
everyone can access PEP services when needed. 
 
Although also important, the information regarding PEP side effects and drug resistance 
as a result of repeated use is not essential as one would get it at the health facility when 
started on the treatment. However, lack of this information may encourage careless 
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behaviour among those who are PEP aware as it may be treated like “the morning after 
pill”.  It is very important that people know that frequent use of PEP can result in drug 
resistance because lack of this information might influence careless behaviour among 
PEP aware individuals. It is also important for potential PEP service seekers to know that 
they would need to be tested prior PEP prescription, so that they can be better prepared 
when they go to seek the services. This study reflected that most respondents were not 
aware of this. 
 
An issue of concern that was brought to light by the study is that some individuals are still 
not well informed about primary measures of prevention, such that they would consider 
medication as a primary measure for prevention, while some still think that HIV can be 
cured. Overall results revealed low awareness and poor knowledge of PEP. 
 
5.2.3 Attitude towards HIV PEP 
 
Initially, questions dealing with attitude were addressed in a somewhat disinhibited 
manner, with most respondents indicating that they were undecided. Significant 
percentages were showing negative attitude by disagreeing with statements such as 
“everyone should have access to PEP”. However, in other questions, majority seemed to 
lean towards a more positive attitude. The study has shown that the knowledge a person 
has on certain practices could greatly affect their attitude towards such practices. A very 
large number of the respondents indicated that they would use PEP if the need arise. 
This, together with the fact that majority also generally felt that PEP was important, is a 
major indicator for a receptive attitude towards the use of PEP. 
 
5.2.4 Utilization of HIV PEP 
 
None of the respondents had ever taken PEP and only a few reported to know of someone 
who had, indicating low uptake not only among the study respondents but also within the 
communities they live in. Uptake of PEP however, is dependent on incidences of 
exposure, if there is no exposure then people will not seek PEP services. With this in 
mind, there are respondents that reported potential exposure (10.4%) and those that 
reported they did not know if they ever have been potentially exposed (43.8%), meaning 
there is potential exposure; people are just not proactive in identifying and addressing it. 
This is in agreement with other studies which revealed mostly favourable attitudes 
towards PEP and its use. One such study was conducted by Monera and Ncube (2014:1) 
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who found out that above 75% respondents had positive attitudes toward HIV PEP, with 
93% expressing willingness to undergo PEP in case of exposure.  
 
5.3 CONCLUSIONS 
 
Through the characteristics of the respondents, the sample proved to be more 
representative of the general adult population of a peri-urban area. Findings revealed that 
knowledge regarding HIV PEP is very poor amongst the respondents and thereby 
amongst the population being represented. Attitudes range from fair to favourable, mainly 
because of lack of knowledge. Utilisation of PEP is very low. The study showed that there 
is lack of knowledge regarding HIV PEP among adults; as a result they are not utilising 
PEP services even though they seem to have a positive attitude towards PEP. 
 
5.4 LIMITATIONS OF THE STUDY 
 
The study was conducted among outpatients in just one public secondary health facility 
in a peri-urban area, where health services are cheap and some free; therefore, attracting 
the lower and middle class population as well as students. Thus, the findings cannot be 
generalized to the entire nation.    
 
The researcher noted that some questions were unanswered in spite of the researcher 
being with the respondents at all times. Employing data collectors might have been 
beneficial as data gaps could have been identified on the spot and addressed 
immediately.   
 
The layout of the questionnaire on the section assessing knowledge encouraged 
complacency. Similar response options were used throughout the section, the researcher 
could have rephrased and rearranged some of the responses such that they were 
structured differently to discourage respondents from selecting answers out of habit. The 
researcher failed to achieve the intended equal representation of both the male and 
female genders because fewer males than females went for outpatient consultations. 
  
5.5 RECOMMENDATIONS 
Based on the findings of this study, the researcher recommends the following:  
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 Similar studies should be conducted in other parts of the country to establish a 
baseline for awareness programs on non-occupational PEP. 
 Studies to determine knowledge, attitude and prescription of both occupational and 
non-occupational PEP amongst health care providers in the country, to determine 
readiness for provision of PEP services should also be conducted.   
 The mass media should be used to educate the general public about PEP as a 
secondary measure for HIV prevention.  
 HIV education given at Health Care facilities should include PEP awareness; it 
should also be part of the information provided during HIV testing and counselling. 
 Inclusion of HIV PEP awareness in health education sessions at St Joseph’s 
hospital and nearby clinics. 
 Advocacy for development of a policy and guidelines specific to non-occupational 
HIV PEP. 
 
5.6 CONCLUDING REMARKS  
 
This study explored the knowledge, attitude and use of HIV PEP among adults at Roma. 
The findings and recommendations should serve to meliorate knowledge of HIV PEP, not 
only at Roma but across the nation, and thereby promoting positive attitudes that will 
result in Basotho accessing HIV PEP services when necessary.  The study is a clear 
indication that there is a need to strengthen the HIV information being disseminated. The 
Government of Lesotho through the Ministry of Health and all stakeholders should make 
every effort to curb the HIV pandemic. Every Mosotho should play their part in achieving 
the sustainable development goals and strive towards ending the HIV/AIDS pandemic by 
the year 2030.  
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ANNEXURE 4A: Consent form (English) 
 
Part 1: Information sheet 
 
Ethics clearance reference number: REC-012714-039 
Research permission reference number: HSHDC/469/2015 
 
Title: ASSESSMENT OF KNOWLEDGE, ATTITUDES AND UTILISATION OF HIV 
POST-EXPOSURE PROPHYLAXIS AMONG ADULTS, ROMA, LESOTHO 
 
Dear Prospective Participant 
 
My name is Maselobe Lebona. I am currently registered for a Master of Arts in Nursing 
Science with the University of South Africa (UNISA) and have to complete a dissertation 
as part of the requirements for the programme. The title of my intended study is as follows: 
Assessment of knowledge, attitudes and utilisation of hiv Post-Exposure 
Prophylaxis among adults, Roma, Lesotho. The study will be supervised by 
Professor AH. Mavhandu-Mudzusi, in the Department of Health Studies. I am requesting 
you to participate in this study.  
 
WHAT IS THE PURPOSE OF THE STUDY? 
The purpose of the study is to determine knowledge, attitudes and utilisation of HIV 
Post-Exposure Prophylaxis among adults in Roma Lesotho in order to develop a 
communication strategy for promoting the use of PEP among adults in Roma, Lesotho  
 
WHY AM I BEING INVITED TO PARTICIPATE? 
You were chosen randomly as an adult out-patient at St Joseph’s Hospital. You will be 
participating in the study with 95 other out-patients. 
 
WHAT IS THE NATURE OF MY PARTICIPATION IN THIS STUDY? 
As a participant, you will be required to complete a questionnaire. The questionnaire 
consists of multiple-choice questions with options to choose from, questions in the form 
of a checklist and a few questions that require responses in writing. The questionnaire 
will require approximately 20 minutes of your time. 
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CAN I WITHDRAW FROM THIS STUDY EVEN AFTER HAVING AGREED TO 
PARTICIPATE? 
Your participation is completely voluntary, you are free to refuse to participate, to withdraw 
your consent (if the questionnaire has not yet been submitted) or to discontinue 
participating in the study at any point you feel you need to without having to explain, and 
you will suffer no penalty or loss. If you do decide to take part, you will be given this 
information sheet to keep and be asked to sign a written consent form.  
 
WHAT ARE THE POTENTIAL BENEFITS OF TAKING PART IN THIS STUDY? 
There will be no direct benefits or compensation to you for taking part in the study, 
however the researcher hopes the findings will help benefit the Nation in the fight against 
HIV/AIDS. 
 
ARE THERE ANY NEGATIVE CONSEQUENCES FOR ME IF I PARTICIPATE IN THE 
RESEARCH PROJECT? 
You will suffer no harm by taking part in the study, and the researcher guarantees 
anonymity to ensure that no information obtained from you as a participant leaks. The 
researcher however apologises in advance for any inconvenience that may result from 
your taking part in the study. 
 
WILL THE INFORMATION THAT I CONVEY TO THE RESEARCHER AND MY 
IDENTITY BE KEPT CONFIDENTIAL? 
 Only the researcher and or the fieldworker, having delivered the questionnaire to you, 
will know about your involvement in this research and no one will be able to connect you 
to the answers you give. Even the researcher will not be able to connect the data to 
individual respondents as completed questionnaires will be dropped in boxes placed at 
different stations at the Hospital, and findings will be generalized. Only the researcher will 
have access to the data, and all data will be kept under lock and key at the researcher’s 
office. Note however that, if necessary, your answers may be reviewed by people 
responsible for making sure that research is done properly, including the transcriber, 
external coder, and members of the Research Ethics Review Committee.  
 
The information you provide may be used in the research report or in journal articles 
should the study be submitted for publication, however individual respondents will not be 
identifiable. 
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HOW WILL THE RESEARCHER(S) PROTECT THE SECURITY OF DATA? 
Hard copies of your answers will be stored by the researcher for a period of five years in 
a locked filing cabinet at the researcher’s office for future research or academic purposes; 
electronic information will be stored on a password protected computer. Future use of the 
stored data will be subject to further Research Ethics Review and approval if applicable. 
Hard copies will be shredded and/or electronic copies will be permanently deleted from 
the hard drive of the computer if necessary.  
 
WILL I RECEIVE PAYMENT OR ANY INCENTIVES FOR PARTICIPATING IN THIS 
STUDY? 
Respondents will not receive any form of payment or incentives for taking part in the 
study. Should respondents incur any costs as a result of the study, the researcher will 
refund them accordingly. 
 
HAS THE STUDY RECEIVED ETHICS APPROVAL 
The study has received ethical clearance from the Research Ethics Review Committee 
of the Departmental Higher Degrees Committee at Unisa. Permission is also granted by 
Department of Health. Permission is also obtained from the hospital management.  
 
HOW WILL I BE INFORMED OF THE FINDINGS/RESULTS OF THE RESEARCH? 
If you would like to be informed of the final research findings, please contact the 
researcher, Maselobe Lebona, on +26657682483 or mslblebona519@gmail.com.  
Should you require any further information or want to contact the researcher about any 
aspect of this study, please contact the above mentioned person.  
 
Should you have concerns about the way in which the research has been conducted, you 
may contact +27124292055 or mmudza@unisa.ac.za. Alternatively, contact Professor L 
Roets, the research ethics chairperson of the Departmental Higher Degrees Committee 
at Unisa.  
 
Thank you for taking time to read this information sheet and for participating in this study. 
 
Thank you. 
 75 
 
 
……………………… 
Maselobe A. Lebona 
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Part 2: Respondent consent 
 
CONSENT TO PARTICIPATE IN THIS STUDY 
 
I, __________________ (participant name), confirm that the person asking my consent 
to take part in this research has told me about the nature, procedure, potential benefits 
and anticipated inconvenience of participation.  
 
I have read (or had explained to me) and understood the study as explained in the 
information sheet.   
 
I have had sufficient opportunity to ask questions and am prepared to participate in the 
study.  
 
I understand that my participation is voluntary and that I am free to withdraw at any time 
without penalty (if applicable). 
 
I am aware that the findings of this study will be processed into a research report, journal 
publications and/or conference proceedings, but that my participation will be kept 
confidential unless otherwise specified.  
 
I agree to the recording of the questionnaire.  
 
I have received a signed copy of the informed consent agreement. 
 
Participant Signature……………………………………………..Date………………… 
 
Researcher’s Name & Surname…………………………………(please print) 
 
Researcher’s signature…………………………………………..Date………………… 
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ANNEXURE 4B: Consent form (Sesotho) 
 
 Part 1: Information sheet 
Ethics clearance reference number: REC-012714-039 
Research permission reference number: HSHDC/469/2015 
 
Title: ASSESSMENT OF KNOWLEDGE, ATTITUDES AND UTILIZATION OF HIV 
POST-EXPOSURE PROPHYLAXIS AMONG ADULTS SEEKING OUT-PATIENT 
SERVICES AT ST JOSEPH’S HOSPITAL IN ROMA, LESOTHO. 
 
HO EA TLANG HO NKA KAROLO, 
 
Lebitso la ka ke Maselobe Lebona, ke ntse ke etsa boithuto le Professor Mavhandu-
Mudzusi, lekaleng la lithuto tsa Bophelo, ke ithutela lengolo la “Master’s”. 
 
Ke u memela ho nka karolo boithutong bona: Tlhahlobo ea tsebo, maikutlo, le ts’ebeliso 
ea litlhare tse thibelang ts’oaetso ea HIV kamora ho hahlameloa/thetsoa ke maro a nang 
le ts’oaetso ea kokoana-hloko ena (PEP), bathong ba baholo Roma, Lesotho. 
 
MORERO OA BOITHUTO KE OFE? 
 
Boithuto bona ke bo etsa ho batlisisa hore na Basotho bana le tsebo e kae ka litlhare 
tsena tsa PEP, le hore na maikutlo a bona mabapi le tsona ke afe, le ho tseba hore na 
ba ea li sebelisa na. 
 
HOBANENG KE MEMETSOE BOITHUTONG BONA? 
 
U memiloe feela hobane u le e mong ua bakuli ba batho ba baholo sepetleleng  sena sa 
St Joseph Roma. U tla kena lipatlisisong tsena le bakuli ba bang ba mashome a robong 
le metso e mehlano. 
 
EBE KAROLO EA KA BOITHUTONG BONA KE EA MOFUTA OFE NA? 
 
Joalo ka mo-nka karolo, u tla tlatsa foromo ea lipotso (questionnaire). Foromo ena e 
kenyelelitse lipotso tse nang le likarabo moo u ka ikhethelang karabo e arabelang litaba 
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tsa hau ebe u ts’oaea e nepahetseng, tse ling tsa lipotso tsena li hloka likarabo tse 
ngoloang. Lipotso tsena li tla nka feela metsotso e ka bang mashome a mabeli a nako ea 
hau. 
 
ANA NKA KHETHA HO ITOKOLLA BOITHUTONG BOO LE HA KE NE KE SE KE ILE 
KA ITLAMA HO NKA KAROLO? 
 
Ho nka karolo ke boikhethelo ba hau, u lokolohile hore u ka hana ho nka karolo, u ka 
itokolla boitlamong (haeba foromo ea lipotso e ntse ele matsohong a hau), kapa hona  ho 
emisa ho nka karolo boithutong neng kapa neng ha u utloa ho hlokahala, ntle le ho fana 
ka mabaka, mme u  ke ke ua lahleheloa ke letho kapa hona ho nyefoloa ka tsela efe kapa 
efe.  Ha u nka qeto ea ho nka karolo, u tla fuoa kh’opi (copy) ea tokomane ena hore ebe 
ea hau, mme u tla tekena lengolo la boitlamo. 
 
KE TLA UNA MELEMO EFE KA HO NKA KAROLO? 
 
Ha ho na melemo eo u tlang ho e una ka kotloloho, kapa eona patala ha u nka karolo 
boithutong, empa moithuti (researcher) o ts’epa  hore boithuto bona botla tsoela sechaba 
ka kakaretso molemo toants’ong ea HIV/AIDS.  
 
NA HO TLA BA LE LITLA-MORAO TSE BOSULA HO NNA HA KE NKA KAROLO 
BOITHUTONG BOO?  
 
U ke ke ua lemala ka tsela efe kapa efe ha u nka karolo boithutong, mme moithuti u itlama 
hore lebitso la hau ha le na ho hlahella litabeng. Le ha ho le joalo moithuti o kopa ts’oarelo 
e sa le joale ka ts’itiso e ka bakoang ke ho nka karolo hoa hau boithutong bona. 
 
NA LITABA TSEO KE TLA FANA KA TSONA HO MOITHUTI LE BOITSIBISO BA KA 
ETLA BA LEKUNUTU? 
 
Ke moithuti feela, le mothusi oa hae, ka mora ho u fa foromo ea lipotso, ba tlang ho tseba 
ka ho nka karolo hoa hau boithutong bona.  Ha ho e mong ea tlang ho u amahanya le 
litaba tseo u tlang ho fana ka tsona. Le eena moithuti a ke ke a ba le bokhoni ba ho 
amahanya ba nkileng karolo le litaba hobane liforomo tsa lipotso tse tlatsitsoeng  li tla 
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mabokoseng a behiloeng libakeng tse fapakaneng sepetlele moo. Hape liphetho li tla 
akaretsoa.   
 
Ke moithuti feela ea tlang ho ba le monyetla oa ho fihlela liforomo tse tlatsitsoeng, mme 
liforomo tsohle li tla notlelloa ofising ea moithuti. Hlokomela hore ha ho hlokahala likarabo 
tsa hau li ka nna tsa feta tlasa bahlahlobi ho bona hore boithuto bo phethahetse ka nepo.  
 
Litaba tseo u fanang ka tsona li ka nna tsa sebelisoa lingoloeng empa le ha ho le joalo 
mabitso a ba nkileng karolo a ke ke a hlahella. 
 
MOITHUTI O TLA NETEFATSA JOANG TS’IRELETSEHO EA LITABA? 
 
Liforomo tse tlatsitsoeng li tla bolokoa ofising ea moithuti nako ea lilemo tse hlano, ka 
hara lebokose le notletsoeng, moo li ka sebelisoang bakeng sa lipatlisiso tsa ka moso 
kapa ho ithuta; litaba tse kh’omphutheng (computer) tsona li tla sireletsoa ka nomoro ea 
lekunutu.  
Ts’ebeliso ea ka moso ea litaba e tla feta tlasa bahlahlobi hape ha ho hlokahala. 
Ha ho hlokahala, liforomo tse tlatsitsoeng li tla taboloa, mme litaba tse kh’omphuteng li 
tla hlakoleloa ruri.  
 
NA KE TLA FUMANA PATALA KAPA LETHO BAKENG SA HO NKA KAROLO? 
 
U ke ke ua fumana letho bakeng sa ho nka karolo boithutong bona. Empa ha u ka qetella 
u kene lits’enyehelong ka lebaka la boithuto bona, moithuti u tla u khutlisetsa lits’enyehelo 
tse joalo.  
 
 
Na boithuto bo fumane tumello   
Boithuto bo fumane tumello ho tsoa ho Research Ethics Review Committee ea 
Departmental High Degrees Committee UNISA. Tumello e fanoe hape le ke Lekala la 
Bophelo UNISA le ho tsoa ho bookameli ba sepetlele. 
 
 
KE TLA TSEBISOA JOANG KA SE TLANG HO FUMANOA/SEPHETHO 
BOITHUTONG BOO? 
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Ha u na le khahleho ea ho tseba ka sephetho sa boithuto, u ka letsetsa moithuti, 
Maselobe Lebona, linomorong tsena +26657682483 kapa ua romela email ho 
mslblebona519@gmail.com. 
 
Ha u ka hloka litlhalosetso kapa hona ho bua le moithuti letsetsa tsona linomoro tse 
fanoeng kaholimo. 
Ha u ka ba le ho se khotsofale ka tsela eo boithuto bo tsamaisoang ka teng, u ka letsetsa 
linomoro tsena +27124292055, kapa ua romela email ho mmudza@unisa.ac.za. Kapa u 
ka ikopanya le Molulasetulo oa Departmental Higher Degrees Committee maane Unisa, 
e leng Professor L. Roets. 
 
Ke leboha ho nka boikhathatso ba ho bala litaba tsena le ho nka karolo boithutong bona. 
 
Kea leboha. 
 
……………………… 
Maselobe Lebona 
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Part 2: Respondent consent (Sesotho) 
 
BOITLAMO BA HO NKA KAROLO 
 
‘Na, __________________ (lebitso la ea nkang karolo), ke paka hore motho ea batlang 
boitlamo ba ka boithutong bona u ntlhaloselitse ka botlalo semelo, mekhoa le melemo ea 
boithuto.  
 
Ke balile (u ntlhaloselitse) mme ke utloisisa joalo ka ha ho ngoliloe. 
   
Ke bile le monyetla oa ho botsa lipotso mme ke maemong a ho nka karolo boithutong 
bona. 
 
Kea utloisisa hore ho nka karolo hoa ka ke boikhethelo ba ka, mme nka etsa qeto ea ho 
tsoa boithutong bona nako efe kapa efe ntle le litla-morao tse bosula. 
 
Kea utloisisa hore liphetho tsa boithuto bona li tla sebelisoa lingoloeng (research report, 
journals, etc) empa ho nka karolo hoa ka e tla ba lekunutu. 
 
Ke itlama ho tlatsa foromo ea lipotso.  
 
Ke fumane kh’opi e tekennoeng ea boitlamo ba ka. 
 
 
 
Tekeno ea ea nkang karolo…………………………Letsatsi………………… 
 
Lebitso la moithuti……………………………………… 
 
Tekeno ea moithuti……………………………………Letsatsi………………… 
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ANNEXURE 5A: Questionnaire (English) 
 
INSTRUCTIONS:  
Do not write your name in the questionnaire. 
Complete the following items by circling the appropriate response and by writing 
a short response where necessary. 
The questionnaire has four (4) Sections. 
Give your most honest response for each question. 
Complete the questionnaire in black ballpoint pen. 
 
 
SECTION A: DEMOGRAPHIC DATA 
1. What gender are you? 
 Male 
 Female 
  
2. How old are you? 
 18  - 24 years old 
 25 - 29 years old 
 30 – 34 years old 
 35 – 39 years old 
 40 years and older 
  
3. What is your marital status? 
 Single 
 Married 
 Divorced 
 Separated 
 Other (specify)…………………………………………………. 
  
 
4. 
 
Indicate your highest educational qualification. 
 None 
 PSLE 
 JC 
 COSC/Equivalent 
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 Diploma 
 Degree 
 Other (specify)………………………………………………………… 
5. What is your religious background? 
 Christianity 
 Muslim 
 Hinduism 
 Ancestral worship 
 Other (specify)………………………………………………………….. 
  
6. What is your occupation? 
 
……………………………………………………………………………. 
  
 
SECTION  B :KNOWLEDGE 
7 Have you ever heard of Post-Exposure Prophylaxis? 
 Yes 
 No 
  
8 If your answer above is yes, what/who was your source of information? 
 Friend/ Relative 
 Health facility 
 Radio 
 Television 
 Internet 
 Training 
 Written source 
 Other………………………………………………………………….. 
  
9 PEP refers to antiretroviral (ARV) medication used to prevent HIV infection. 
 True 
 False 
 I don’t know 
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10. PEP is medication given to HIV positive people after being tested. 
 True 
 False 
 I don’t know 
  
11. PEP is medication given to HIV negative people to prevent acquisition of HIV 
after being exposed to HIV infected body fluids. 
 True 
 False 
 I don’t know 
  
12. PEP is taken for one week only. 
 True 
 False 
 I don’t know 
  
13. HIV negative people do not need to take PEP. 
 True 
 False 
 I don’t know 
  
14. PEP is given to nurses and doctors only. 
 True 
 False 
 I don’t know 
  
15. PEP can be started 5 days after being exposed to HIV. 
 True 
 False 
 I don’t know 
  
16. You cannot be given PEP when you have been exposed to HIV through 
consensual sexual intercourse. 
 True 
 False 
 I don’t know 
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17. PEP is taken for 28 days only. 
 True 
 False 
 I don’t know 
  
18 PEP is a lifelong medication. 
 True 
 False 
 I don’t know 
  
19 PEP medication has no side effects 
 True 
 False 
 I don’t know 
  
20 PEP medication can be used as a primary preventive measure for HIV. 
 True 
 False 
 I don’t know 
  
21. You need to be tested for HIV before you can receive PEP medication. 
 True 
 False 
 I don’t know 
  
22. PEP can cure HIV. 
 True 
 False 
 I don’t know 
  
23 Frequent use of PEP can cause drug resistance. 
 True 
 False 
 I don’t know 
  
 
SECTION C: ATTITUDE 
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24 PEP in an important measure of HIV prevention. 
 Strongly agree 
 Agree 
 Undecided 
 Disagree 
 Strongly disagree 
  
25 
 
 
Everyone should have access to PEP. 
 Strongly agree 
 Agree 
 Undecided 
 Disagree 
 Strongly disagree 
  
26 PEP can reduce the likelihood of HIV infection. 
 Strongly agree 
 Agree 
 Undecided 
 Disagree 
 Strongly disagree 
  
27 
 
If you had to, would you use PEP? 
 Yes 
 No 
  
28 If you answered No above (27), why would you choose not to? 
 Fear of being stigmatized 
 Fear of possible side effects 
 Other (specify)…………………………………………………………… 
……………………………………………………………………………. 
  
29 PEP can help reduce new HIV infections? 
 Strongly agree 
 Agree 
 Undecided 
 Disagree 
 Strongly disagree 
  
30 What are your general feelings about PEP?................................................   
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……………………………………………………………………………………… 
……………………………………………………………………………………… 
……………………………………………………………………………………… 
……………………………………………………………………………………… 
31 Is your answer above (30) influenced by the following: 
 Culture 
 Religion 
 Peers 
 Other (specify) 
  
 
 SECTION D: UTILISATION 
32 Have you ever taken PEP? 
 Yes 
 No 
  
33 If you answered Yes above (32), what was the reason for taking PEP? 
……………………………………………………………………………………. 
  
34 Do you know of anyone who has taken PEP? 
 Yes 
 No 
  
35 If you answered Yes above (34), what was their reason for taking PEP? 
……………………………………………………………………………………… 
……………………………………………………………………………………… 
  
36 Do you know of anyone who has tried to access PEP services but was unable 
to? 
 Yes 
 No 
  
37 If you answered Yes above (36), why was that individual unable to access 
PEP 
services?.......................................................................................................... 
…………………………………………………………………………………….. 
…………………………………………………………………………………….. 
  
38 Do you think you have ever been exposed to potentially HIV-infected body 
fluids? (e.g. condom slippage/breakage, unanticipated unprotected sexual 
intercourse, exposure to infected blood, etc.) 
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 Yes 
 No 
 I don’t know 
39 If you answered Yes above (38), what did you do after the incident?  
 
 Visited a health care facility 
 Washed the affected area 
 Nothing 
 Other (specify)………………………………………………………. 
  
40 Indicate the reason for your action in the above question?  
……………………………………………………………………………. 
……………………………………………………………………………. 
……………………………………………………………………………. 
  
41 Do you think you acted in the right way (above)?  
 Yes 
 No 
  
 
Thank you 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ANNEXURE 5B: Questionnaire (Sesotho) 
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TATAISO:  
Se ngole lebitso la hau pampiri-potsong ena. 
Araba ka ho ts’oaea karabo e nepahetseng le ka ho ngola ha khuts’oanyanyane  
moo ho hlokahalang libakeng tse fanoeng. 
Pampiri-potso ena e na le likarolo tse nne (4). 
Ka kopo araba lipotso tsohle ka bots’epehi.  
Sebelisa pene e nts’o ho araba lipotso.  
 
 
KAROLO EA A: BOITSEBISO 
1. U motona kapa mots’ehali? 
 Motona 
 Mots’ehali 
  
2. U oela lilemong li feng? 
 18  - 24  
 25 - 29  
 30 – 34  
 35 – 39  
 40 le ho feta 
  
3. Boemo ba hau ba lenyalo ke bofe? 
 Ha ke ea nyaloa/nyala 
 Ke nyetsoe/nyetse 
 Ke hlalile 
 Ke arohane le molekane 
 Ho hong (hlalosa)…………………………………………………. 
  
4. U fihleletse lengolo lefe la sekolo? 
 Ha kena lona 
 PSLE 
 JC 
 COSC/ho ts’oanang 
 Diploma 
 Degree 
 Le leng (hlalosa)………………………………………………………… 
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5. Tumelo ea hau ke efe (kereke)? 
 Mokreste 
 Muslim 
 Hinduism 
 Balimo 
 E nngoe (hlalosa)………………………………………………….. 
  
6. U sebetsa hokae, u le eng? 
……………………………………………………………………………. 
  
  
KAROLO EA  B : TSEBO 
7 Na u kile ua utloela ka litlhare tse thibelang ts’oaetso ea HIV kamora ho 
kopana le maro a nang le tso’aetso (PEP)? 
 E 
 Che 
  
8 Haeba karabo ea hau kaholimo ke E, u ne u utloa litaba tseo hokae/ho 
mang? 
 Motsoalle/ Oa leloko 
 Setsing sa Bophelo 
 Radio 
 Television 
 Marangrang 
 Koetlisong 
 Lingoloeng 
 Ho hong (hlalosa)……………………………………………………..   
  
9 PEP  ke litlhare tsa li ARV tse sebelisoang ho thibela ts;oaetso ea HIV?  
 Ke nnete 
 Ha se nnete 
 Ha ke tsebe 
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10. PEP ke litlhare tse fuoang batho ba nang le ts’oaetso ea HIV ka mora ho 
hlahlojoa.  
 Ke nnete 
 Ha se nnete 
 Ha ke tsebe 
  
11. PEP ke litlhare tse fuoang batho ba sokang ba eba le ts’oaetso ea HIV ho 
thibela hore ba se fumane ts’oaetso ka mora ho hahlangoeloa ke maro a 
‘mele a nang le ts’oaetso.  
 Ke nnete 
 Ha se nnete 
 Ha ke tsebe 
  
12. Litlhare tsa PEP li sebelisoa beke ele nngoe feela.  
 Ke nnete 
 Ha se nnete 
 Ha ke tsebe 
  
13. Batho ba so kang ba eba le ts’oaetso ea HIV ha ba hloke ho noa litlhare tsa 
PEP. 
 Ke nnete 
 Ha se nnete 
 Ha ke tsebe 
  
14. PEP e fuoa manese le lingaka feela. 
 Ke nnete 
 Ha se nnete 
 Ha ke tsebe 
  
16. U ka se fuoe PEP ha u hahlametsoe ke HIV ka mokhoa oa thobalano eo 
uena le molekane le lumellaneng. 
 Ke nnete 
 Ha se nnete 
 Ha ke tsebe 
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17. PEP e nooa matsatsi a mashome a mabeli a metso e robeli (28) feela.  
 Ke nnete 
 Ha se nnete 
 Ha ke tsebe 
  
18 PEP ke litlhare tsa bophelo bohle.  
 Ke nnete 
 Ha se nnete 
 Ha ke tsebe 
  
19 Litlhare tsa PEP ha lina litlamorao. 
 Ke nnete 
 Ha se nnete 
 Ha ke tsebe 
  
20 PEP e ka sebelisoa ese mokhoa oa mantlha oa ho thibela tso’aetso ea HIV. 
 Ke nnete 
 Ha se nnete 
 Ha ke tsebe 
  
21. U hloka ho hlahlobeloa HIV pele u ka fumana PEP. 
 Ke nnete 
 Ha se nnete 
 Ha ke tsebe 
  
22. PEP  e ka folisa HIV. 
 Ke nnete 
 Ha se nnete 
 Ha ke tsebe 
  
23 Ho sebelisa PEP khafetsa ho ka qetella ho etsa hore litlhare tseo li hloke 
matla mmeleng. 
 Ke nnete 
 Ha se nnete 
 Ha ke tsebe 
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KAROLO EA C: MAIKUTLO 
24 PEP ke mokhoa o bohlokoa oa ho thibela ts’oaetso ea HIV. 
 Ke lumela haholo 
 Kea lumela 
 Ha kena qeto 
 Kea hana 
 Ke hana haholo 
  
25 
 
 
Bohle ba tlameha ho fumana PEP ha ho hlokahala.  
 Ke lumela haholo 
 Kea lumela 
 Ha kena qeto 
 Kea hana 
 Ke hana haholo 
  
26 PEP e ka fokotsa menyetla ea ts’oaetso ea HIV.  
 Ke lumela haholo 
 Kea lumela 
 Ha kena qeto 
 Kea hana 
 Ke hana haholo 
  
27 
 
Ha ho se ho hlokahala, na u ka sebelisa PEP? 
 E 
 Che 
  
28 Haeba karabo ea hau kaholimo (27) e bile Che, hobaneng u ka se khethe 
ho sebelisa PEP? 
 Ho ts’aba ho khetholloa 
 Ho ts’aba litlamorao tsa litlhare tsa PEP 
 Ho hong (hlalosa)……………………………………………………… 
……………………………………………………………………………. 
  
29 PEP e ka thusa ho fokotsa ts’oaetso e ncha ea HIV? 
 
 Ke lumela haholo 
 Kea lumela 
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 Ha kena qeto 
 Kea hana 
 Ke hana haholo 
30 Maikutlo a hau ke afe mabapi le PEP?.................................................... 
……………………………………………………………………………………… 
……………………………………………………………………………………… 
……………………………………………………………………………………… 
……………………………………………………………………………………… 
  
31 Karabo ea hau kaholimo (30) e na le ts’uts’umetso ea efeng ho tse latelang? 
 
 Setso 
 Tumelo 
 Metsoalle 
 Ho hong (hlalosa)………………………………………………. 
  
  
 KAROLO EA D: TS’EBELISO 
32 Na ukile ua noa litlhare tsa PEP? 
 E 
 Che 
  
33 Haeba karabo ea hau kaholimo (32) ke E, lebaka ene ele lefe? 
……………………………………………………………………………………. 
  
34 Na ho na le motho eo u mo tsebang ea kileng a noa litlhare tsa PEP? 
 E 
 Che 
  
35 Haeba karabo ea hau kaholimo (34) ke E, lebaka leo motho eo a neng a 
noa litlhare tseo ke lefe?…………………………………………………… 
…………………………………………………………………………………….. 
  
36 Na hona le motho eo u mo tsebang ea kileng a leka ho fumana lits’ebeletso 
tsa PEP empa a hloleha? 
   E 
 Che 
  
37 Haeba karabo ea hau ka holimo (36) ke E, hobaneng ha motho eo a ile a 
sitoa ho fumana lits’ebeletso tse joalo? 
.......................................................................................................... 
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…………………………………………………………………………………….. 
…………………………………………………………………………………….. 
38 Na u nahana hore u kile ua hahlameloa ke ts’oaetso ea HIV ka tsela ea 
maro a mmele? (jk. Ho chophoha/taboha hoa khohlopo (condom) nakong 
ea thobalano, thobalano e sa ts’ireletsehang e neng e sa lebelloa, ho thetsa 
mali, joalojoalo)  
 E 
 Che 
 Ha ke tsebe 
  
39 Haeba karabo ea hau ka holimo (38) ke E, u ile ua etsa eng ka morao ho 
ketsahalo eo?  
 Ka etela lekala la Bophelo 
 Ka hlapa moo khahlamelo e bileng teng 
 Letho 
 Ho hong (hlalosa)………………………………………………………. 
 
  
40 Lebaka leo u ileng ua nka qeto e kaholimo (39) ka lona ke lefe?  
……………………………………………………………………………. 
……………………………………………………………………………. 
……………………………………………………………………………. 
  
41 U nahana qeto eo u ileng ua e nka (ka holimo) e ne e nepahetse?  
 E 
 Che 
  
 
Kea leboha 
 
 
 
 
 
 
